chuong 12

464 CMDT 2013

12 AtherOsclerOtic peripherAl

VAscUlAr DiseAse

OCClusive Disease: aOrTa & iliaC arTeries

` `̀̀̀̀̀`̀̀̀`

Claudication: cramping pain or tiredness in the ` `̀̀̀̀̀`̀̀̀`

calf, thigh, or hip while walking.

Diminished femoral pulses.` `̀̀̀̀̀`̀̀̀`

Tissue loss (ulceration, gangrene) or rest pain.` `̀̀̀̀̀`̀̀̀`

EssEnT ials of D iagnos is

General Considerations``

Occlusive atherosclerotic lesions can develop in the vessels of the legs and, less commonly, the arms. These peripheral lesions are symptoms of a systemic atherosclerotic process. Pathologic changes of atherosclerosis may be diffuse, but flow-limiting stenoses occur segmentally. In the lower extremities, they classically occur in three anatomic segments: the aor-toiliac segment, femoral-popliteal segment, and the infrapo-pliteal or tibial segment of the arterial tree. Lesions in the distal aorta and proximal common iliac arteries often occur in men aged 50–60 years. The patient with aortoiliac disease is usually a smoker and the aortoiliac disease may be the initial manifestation of systemic atherosclerosis. Disease progression may lead to complete occlusion of one or both common iliac arteries, which can precipitate occlusion of the entire abdom-inal aorta to the level of the renal arteries. Lesions affecting the external iliac arteries are less common as are lesions isolated to the aorta. This is particularly true of younger patients with isolated aortoiliac disease, ie, with no involvement of the more distal vessels of the lower extremities.

Clinical Findings``

a. symptoms and signs

Pain occurs because blood flow cannot keep up with the increased demand of exercise. This pain, termed “claudi-cation,” is defined as pain on exertion. It is typically

described as severe and cramping, and it primarily occurs in the calf muscles. The pain may extend into the thigh and buttocks with continued exercise. It may be bilateral if there is bilateral disease. Although generally reproduc-ible, there is day-to-day variation in severity, and thus it is termed “intermittent claudication.” Rarely, patients complain only of weakness in the legs when walking, or simply extreme limb fatigue. The symptoms are relieved with rest. With bilateral common iliac disease, erectile dysfunction is a common complaint. Femoral pulses are absent or very weak as are the distal pulses. A bruit may be heard over the aorta, iliac, or femoral arteries or over all three arteries.

B. Doppler Findings

The ratio of systolic blood pressure detected by Doppler examination at the ankle compared with the brachial artery is reduced to below 0.9 (normal ratio is 1.0–1.2); this difference is exaggerated by exercise. By convention, the higher pedal pressure is used for calculation. Segmental waveforms or pulse volume recordings obtained by strain gauge technology through blood pressure cuffs demonstrate blunting of the arterial inflow throughout the lower extremity.

C. imaging

CT angiography (CTA) and magnetic resonance angiogra-phy (MRA) have largely replaced invasive angiography to determine the anatomic location of disease. Imaging is only required when symptoms require intervention, since a history and physical examination with segmental wave-form analysis should appropriately identify the involved levels of the arterial tree.

Treatment``

a. Conservative Care

A program that includes smoking cessation; risk factor reduction; weight loss; and consistent, moderate exercise will substantially improve walking distance. In patients with peripheral artery disease, nicotine replacement ther-apy, bupropion, and varenicline have established benefits

Blood Vessel & lymphatic DisordersJoseph H. Rapp, MDChristopher D. owens, MD, MscMeshell D. Johnson, MD

BlOOD Vessel & lymphAtic DisOrDers 465 CMDT 2013

ACCF/AHA focused update of the guideline for the manage-ment of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2011 Nov 1;124(18):2020–45. [PMID: 21959305]

Bachoo P et al. Endovascular stents for intermittent claudica-tion. Cochrane Database Syst Rev. 2010 Jan 20;(1):CD003228. [PMID: 20091540]

Le Faucheur A et al. Variability and short-term determinants of walking capacity in patients with intermittent claudication. J Vasc Surg. 2010 Apr;51(4):886–92. [PMID: 20347684]

Linnemann B et al. Variability of non-response to aspirin in patients with peripheral arterial occlusive disease during long-term follow-up. Ann Hematol. 2009 Oct;88(10):979–88. [PMID: 19247655]

OCClusive Disease: superFiCial & COMMOn FeMOral & pOpliTeal arTeries

` `̀̀̀̀̀`̀̀̀`

Cramping pain or tiredness in the calf with exercise.` `̀̀̀̀̀̀̀̀̀`

Reduced popliteal or pedal pulses.` `̀̀̀̀̀`̀̀̀`

foot pain at rest, relieved by dependency.` `̀̀̀̀̀`̀̀̀`

foot gangrene or ulceration.` `̀̀̀̀̀`̀̀̀`


General Considerations ``

The superficial femoral artery is the artery most commonly occluded by atherosclerosis. The disease frequently occurs where the superficial femoral artery passes through the abductor magnus tendon in the distal thigh (Hunter canal). The common femoral artery and the popliteal artery are less commonly diseased but lesions in these vessels are debilitating, resulting in short-distance claudication. As with atherosclerosis of the aortoiliac segment, these lesions are closely associated with a history of smoking.

Clinical Findings ``


Symptoms of intermittent claudication caused by lesions of the common femoral artery, superficial femoral artery, and popliteal artery are confined to the calf. Occlusion or stenosis of the superficial femoral artery at the adductor canal when the patient has good collateral vessels from the profunda femoris will cause claudication at approximately 2–4 blocks. However, with concomitant disease of the profunda femoris or the popliteal artery, much shorter distances may trigger symptoms. With short-distance claudication, dependent rubor of the foot with blanching on elevation may be present. Chronic low blood flow states will also cause atrophic changes in the lower leg and foot with loss of hair, thinning of the skin and subcutaneous tissues, and disuse atrophy of the muscles. With segmental occlusive disease of the superfi-cial femoral artery, the common femoral pulsation is normal, but the popliteal and pedal pulses are reduced.

in smoking cessation. A trial of phosphodiesterase inhibi-tors, such as cilostazol 100 mg orally twice a day, may be beneficial in approximately two-thirds of patients. Antiplatelet agents reduce overall cardiovascular morbid-ity but do not ameliorate symptoms. Several large trials have failed to show a benefit from warfarin therapy. In the initial stages of a rehabilitation program, simply slowing the cadence of walking will allow patients to walk further without pain.

B. endovascular Techniques

When the atherosclerotic lesions are truly segmental, they can be effectively treated with angioplasty and stenting. This approach matches the results of surgery for single stenoses but both effectiveness and durability decreases with longer or multiple stenoses.

C. surgical intervention

A prosthetic aorto-femoral bypass graft that bypasses the diseased segments of the aortoiliac system is a highly effec-tive and durable treatment for this disease. Patients may be treated with a graft from the axillary artery to the femoral arteries (axillo-femoral bypass graft) or, in the unusual case of iliac disease limited to one side, a graft from the contral-ateral femoral artery (fem-fem bypass). The axillo-femoral and femoral to femoral grafts have lower operative risk; however, they are less durable.

Complications``

The complications of the aorto-femoral bypass are those of any major abdominal reconstruction in a patient popula-tion that has a high prevalence of cardiovascular disease. Mortality should be low, in the range of 2–3%, but mor-bidity is higher with a 5–10% rate of myocardial infarction. The total complication rate may be >10%. Complications of endovascular repair include rupture of heavily calcified arteries, embolization, and vessel dissection. These are rela-tively uncommon and the total complication rate should be <3%.

prognosis ``

Without intervention patients with aortoiliac disease may have a further reduction in walking distance but symptoms rarely progress to rest pain or threatened limb loss. Life expectancy is limited by their attendant cardiac disease with a mortality rate of 25–40% at 5 years.

Symptomatic relief is generally excellent after interven-tion. After aorto-femoral bypass, a patency rate of 90% at 5 years is common. Patency rates and symptom relief for less extensive procedures are also good with 20–30% symp-tom return at 3 years.

When to refer``

Patients with progressive reduction in walking distance and those with limitations in ambulation that interfere with their activities of daily living should be referred for consul-tation to a vascular surgeon.

chApter 12466 CMDT 2013

rates of endovascular therapy are 1–5%, making these therapies attractive despite their lower durability.

prognosis ``

The prognosis for motivated patients with isolated superfi-cial femoral artery disease is excellent, and surgery is not recommended for mild or moderate claudication in these patients. However, when claudication significantly limits daily activity and undermines quality of life as well as over-all cardiovascular health, intervention may be warranted. All interventions require close postprocedure follow-up with ultrasound surveillance so that any recurrent narrow-ing can be treated promptly to prevent complete occlusion. The reported patency rate of bypass grafts of the femoral artery, superficial femoral artery, and popliteal artery is 65–70% at 3 years whereas the patency of angioplasty is less than 50% at 3 years.

Because of the extensive atherosclerotic disease, includ-ing associated coronary lesions, 5-year mortality among patients with lower extremity disease can be as high as 50%, particularly with involvement of the infrapopliteal vessels (see below). However, with aggressive risk factor modification, substantial improvement in longevity has been reported.

When to refer``

Patients with progressive symptoms, short distance claudi-cation, rest pain, or any ulceration should be referred to a peripheral vascular specialist.

Bradbury AW et al; BASIL trial Participants. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: analysis of amputation free and overall survival by treatment received. J Vasc Surg. 2010 May;51(5 Suppl):18S–31S. [PMID: 20435259]

Conte MS. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) and the (hoped for) dawn of evidence-based treatment for advanced limb ischemia. J Vasc Surg. 2010 May;51(5 Suppl):69S–75S. [PMID: 20435263]

Forbes JF et al; BASIL trial Participants. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Health- related quality of life outcomes, resource utilization, and cost- effectiveness analysis. J Vasc Surg. 2010 May;51(5 Suppl): 43S–51S. [PMID: 20435261]

Torpy JM et al. JAMA patient page. Peripheral arterial disease. JAMA. 2009 Jan 14;301(2):236. [PMID: 19141772]

White C. Intermittent claudication. N Engl J Med. 2007 Mar 22; 356(12):1241–50. [PMID: 17377162]

OCClusive Disease: lOWer leG & FOOT arTeries

` `̀̀̀̀̀`̀̀̀`

severe pain of the forefoot that is relieved by ` `̀̀̀̀̀`̀̀̀`

dependency.

Pain or numbness of the foot with walking.` `̀̀̀̀̀`̀̀̀`

Ulceration or gangrene of the foot or toes. ` `̀̀̀̀̀`̀̀̀`

Pallor when the foot is elevated.` `̀̀̀̀̀`̀̀̀`


B. laboratory Findings

The ankle-brachial index (ABI) is reduced; levels below 0.5 suggest severe reduction in flow. ABI readings depend on arterial compression. Since the vessels may be calcified in diabetic patients and the elderly, ABIs can be misleading and must be accompanied by a waveform analysis. Pulse volume recordings with cuffs placed at the high thigh, mid thigh, calf, and ankle will delineate the levels of obstruction with reduced pressures and blunted waveforms. Angiography, CTA, or MRA all adequately show the ana-tomic location of the obstructive lesions. Generally, these studies are only done if revascularization is planned.

Treatment ``

a. Conservative Care

As with aortoiliac disease, conservative management has an important role for some patients, particularly those indi-viduals with superficial femoral artery occlusion and good profunda femoris collateral vessels. For these patients con-servative management as noted above can result in excel-lent outcomes with no intervention required.

B. surgical intervention

1. Bypass surgery—Intervention is indicated if intermit-tent claudication is progressive, incapacitating or interferes significantly with essential daily activities. Intervention is mandatory if there is rest pain or threatened tissue loss of the foot. The most effective and durable treatment for lesions of the superficial femoral artery is a femoral-popliteal bypass with autogenous saphenous vein. Synthetic material, usually polytetrafluoroethylene (PTFE), can be used, but these grafts do not have the durability of vein bypass.

2. endovascular surgery—Endovascular techniques may be effective for lesions of the superficial femoral artery. The BASIL trial found similar short-term results for surgery and angioplasty but worse long-term outcomes with angioplasty. Angioplasty may be combined with stenting either with a bare metal stent or a PTFE-covered stent to prevent elastic recoil of the vessel or if a dissection occurs following angioplasty. These techniques have lower mor-bidity than bypass surgery but also have a lower rate of success and durability.

Endovascular therapy is most effective when the lesions are <10 cm long and in patients who are undergoing aggressive risk factor modification.

3. Thromboendarterectomy—Removal of the atheroscle-rotic plaque is limited to the lesions of the common femoral and the profunda femoris artery where bypass grafts and endovascular techniques have a more limited role.

Complications ``

Open surgical procedures of the lower extremity, particu-larly long bypasses with vein harvest, have a risk of wound infection that is higher than in other areas of the body. Wound infection or seroma can occur in as many as 15–20% of cases. Myocardial infarction rates after open surgery are 5–10%, with a 1–4% mortality rate. Complication


a. Bypass and endovascular Techniques

Bypass with vein to the distal tibial or pedal arteries has been shown to be an effective mechanism to treat rest pain and heal gangrene or ischemic ulcerations of the foot. Because the foot often has relative sparing of vascular dis-ease, these bypasses have had adequate patency rates (70% at 3 years). Fortunately, in nearly all series, limb salvage rates are much higher than patency rates.

Endovascular techniques are beginning to be used in the tibial vessels with modest results, but bypass grafting remains the primary technique of revascularization.

B. amputation

Patients with rest pain and tissue loss are at high risk for amputation, particularly if revascularization cannot be done. It may be necessary to debride necrotic or severely infected tissue. Amputations of the second through fifth toes may have little or no effect on the mechanics of walk-ing. However, removal of the first toe or a transmetatarsal amputation, removing all toes and the heads of the metatar-sals, are durable but increase the energy required of walking by 5–10%. Unfortunately, the next level that can be success-fully used for a prosthesis is at the below-knee level. The energy expenditure of walking is then increased by 50%. With an above-knee amputation, the energy required to ambulate may be increased as much as 100%. While there are good prosthetic alternatives for these patients, activity levels are limited after amputation, and there are issues relating to self-image. These factors combine to demand revascularization whenever possible to preserve the limb.

Complications``

The complications of intervention are similar to those listed for superficial femoral artery disease with evidence that the overall cardiovascular risk increases with decreasing ABI. The patients with critical limb ischemia require aggressive risk factor modification. Wound infection rates after bypass are higher if there is an open wound in the foot.

prognosis``

Patients with tibial atherosclerosis have extensive athero-sclerotic burden and a high prevalence of diabetes. Their prognosis without intervention is poor and complicated by the risk of amputation.

When to refer``

Patients with diabetes should be referred to a vascular specialist for evaluation if pedal pulses are reduced (even slightly) and if ulcers are present (even if small). Intervention may not be necessary but the severity of the disease will be quantified, which has implications for future symptom development.

Martens JM et al. Update on PADI trial: percutaneous translu-minal angioplasty and drug-eluting stents for infrapopliteal lesions in critical limb ischemia. J Vasc Surg. 2009 Sep;50(3):687–9. [PMID: 19700099]


Occlusive processes of the lower leg and foot primarily involve the tibial vessels with rare involvement of the arter-ies of the foot. There often is extensive calcification of the artery wall. Diabetes mellitus is a risk factor for this distri-bution of atherosclerosis.



Unless there are associated lesions in the aortoiliac or femoral/superficial femoral artery segments, claudication may not be evident. The gastrocnemius and soleus muscles may receive adequate blood supply from collateral vessels from the popliteal artery; therefore, when disease is iso-lated to the tibial vessels, there may be foot ischemia with-out attendant claudication, and rest pain or ulceration may be the first sign of severe vascular insufficiency. Classically, rest pain is confined to the dorsum of the foot at the area of the metatarsal heads and is relieved with dependency. The pain is severe, usually burning in character and will awaken the patient from sleep. Because of the high inci-dence of neuropathy in these patients, it is important to differentiate rest pain from neuropathic dysesthesia. If the pain is relieved by simply dangling the foot over the edge of the bed, which increases blood flow to the foot, then the rest pain is due to vascular insufficiency. On examination, depending on whether associated proximal disease is pres-ent, there may or may not be femoral and popliteal pulses, but the pedal pulses will be absent. Dependent rubor may be prominent with pallor on elevation. The skin of the foot is generally cool, atrophic, and hairless.


The ABI may be quite low (in the range of 0.3 or lower), but ABIs may be falsely elevated because of the noncom-pressability of the calcified tibial vessels. Waveform analysis is important in these patients; a monophasic flow pattern denotes critically low flow. Segmental pulse volume recordings will show a fall-off in blood pressure between the calf and ankle, although pulse volume recordings also may also be affected by tibial vessel calcification.

C. imaging

MRA or angiography is often needed to delineate the anatomy of the tibial-popliteal segment. CTA is less helpful for detection of lesions in this location.

Treatment ``

Good foot care may avoid ulceration, and most diabetic patients will do well with a conservative regimen. However, if ulcerations appear and there is no significant healing within 2–3 weeks, revascularization will be required. Poor blood flow or infrequent rest pain is not an absolute indi-cation for revascularization. However, rest pain occurring nightly with monophasic waveforms requires revascular-ization to prevent threatened tissue loss.



There will be little or no flow found with Doppler exami-nation of the distal vessels. Imaging, if done, may show an abrupt cutoff of contrast with embolic occlusion. Blood work may indicate systemic acidosis.

C. imaging

Whenever possible, imaging should be done in the operat-ing room because obtaining angiography, MRA, or CTA may delay revascularization and jeopardize the viability of the extremity. However, in cases with only modest symp-toms and where light touch of the extremity is maintained, imaging may be helpful in planning the revascularization procedure.

Treatment ``

Immediate revascularization is required in all cases of symptomatic acute arterial thrombosis. Evidence of neuro-logic injury, including loss of light touch sensation, indicates that collateral flow is inadequate to maintain limb viability and revascularization should be accomplished within 3 hours. Longer delays carry a significant risk of irreversible tissue damage. This risk approaches 100% at 6 hours.

a. Heparin

As soon as the diagnosis is made, unfractionated heparin should be administered (5000–10,000 units) intravenously. This helps prevent clot propagation and may also help relieve associated vessel spasm. There may be some reduc-tion in symptoms with aggressive anticoagulation, but revascularization will still be required.

B. endovascular Techniques

Catheter directed chemical thrombolysis into the clot with TPA may be done but often requires 24 hours or longer to fully lyse the thrombus. This approach can be taken only in patients with an intact neurologic exam. An echocardio-gram should be done to identify additional clot in the atrium. Catheter-based local mechanical thrombolysis may be an excellent alternative.

C. surgical intervention

General anesthesia is usually indicated; local anesthesia may be used in extremely high-risk patients if the explora-tion is to be limited to the common femoral artery. In extreme cases, it may be necessary to perform embolec-tomy from the femoral, popliteal and even the pedal vessels to revascularize the limb. Devices to pulverize and aspirate clot and intraoperative thrombolysis with tissue plasmino-gen activator (TPA) are being used to improve outcomes.

Complications ``

Complications of revascularization of an acutely ischemic limb can include severe acidosis and myocardial arrest.

Raghunathan A et al. Postoperative outcomes for patients under-going elective revascularization for critical limb ischemia and intermittent claudication: a subanalysis of the Coronary Artery Revascularization Prophylaxis (CARP) trial. J Vasc Surg. 2006 Jun;43(6):1175–82. [PMID: 16765234]

Torpy JM et al. JAMA patient page. Peripheral arterial disease. JAMA. 2009 Jan 14;301(2):236. [PMID: 19141772]

aCuTe arTerial OCClusiOn OF a liMB

` `̀̀̀̀̀`̀̀̀`

sudden pain in an extremity. ` `̀̀̀̀̀`̀̀̀`

generally associated with some element of neu-` `̀̀̀̀̀`̀̀̀`

rologic dysfunction with numbness, weakness, or complete paralysis.

absent extremity pulses.` `̀̀̀̀̀`̀̀̀`



Acute occlusion may be due to an embolus or to throm-bosis of a diseased atherosclerotic segment. Arterial to arterial emboli can occur, but emboli large enough to occlude proximal arteries in the lower extremities are almost always from the heart. Over 50% of the emboli from cardiac sources go to the lower extremities, 20% to the cerebrovascular circulation, and the remainder to the upper extremities and mesenteric and renal circulation. Atrial fibrillation is the most common cause of cardiac thrombus formation; other causes are valvular disease or ischemic heart disease where thrombus has formed on the ventricular surface of a transmural myocardial infarct.

Emboli from arterial sources such as arterial ulcerations or calcified excrescences are usually small and go to the distal arterial tree (toes).

The typical patient with primary thrombosis has had a history of claudication and now has an acute occlusion. If the stenosis has developed over time, collateral blood ves-sels will develop, and the resulting occlusion may only cause a minimal increase in symptoms.



The sudden onset of extremity pain, with loss or reduction in pulses, is diagnostic of acute arterial occlusion. This often will be accompanied by neurologic dysfunction, such as numbness or paralysis in extreme cases. With popliteal occlusion, symptoms may only affect the foot. With proxi-mal occlusions, the whole leg may be affected. Signs of severe arterial ischemia include pallor on elevation, cool-ness of the extremity, and mottling. Impaired neurologic function progressing to anesthesia accompanied with paralysis suggest a poor prognosis.


Signs of cerebrovascular disease include bruits in the mid-cervical area. However, they are not specific for nar-rowing within the vessel. There is poor correlation between the degree of stenosis and the presence of the bruit. Furthermore, absence of a bruit does not exclude the pos-sibility of carotid stenosis. Nonfocal symptoms, such as dizziness and unsteadiness, seldom are related to cerebro-vascular atherosclerosis.

B. imaging

Duplex ultrasonography is the imaging modality of choice with a high specificity and sensitivity for detecting and grading the degree of stenosis at the carotid bifurcation: 50% stenosis in a symptomatic patient and 80% in an asymptomatic patient require intervention. Mild to moder-ate disease (30–50% stenosis) indicates the need for ongo-ing surveillance and aggressive risk factor modification.

Excellent depiction of the full anatomy of the cerebro-vascular circulation from arch to cranium can be obtained with either MRA or CTA. Each of these modalities may have false-positive or false-negative findings. Since the decision to intervene in cases of carotid stenosis depends on an accurate assessment of the degree of stenosis, it is recommended that at least two modalities be used to con-firm the degree of stenosis. Cerebral angiography is reserved for cases that cannot be resolved by MRA or CTA.

Treatment``

a. asymptomatic patients

Patients with no neurologic symptoms but with carotid stenosis on imaging will benefit from carotid intervention if they are considered to be at low risk for intervention and their expected survival is > 5 years. Recommendation for intervention also presumes that the treating institution has a stroke rate in asymptomatic patients that is acceptable (< 3%). Large studies indicate a reduction in stroke rate from 11.5% to 5.0% over 5 years with surgical treatment of asymptomatic carotid stenoses of > 60%. However, the usual practice is to only treat those patients who have > 80% stenosis. Patients with carotid stenosis that suddenly worsens are thought to have an unstable plaque and are at particularly high risk for embolic stroke.

B. symptomatic patients

Large randomized trials have shown that patients with TIAs or strokes from which they have completely or nearly completely recovered will benefit from carotid intervention if the ipsilateral carotid artery has a stenosis of ≥70%, and they are likely to derive benefit if the artery has a stenosis of 50–69%. In these situations, carotid endarterectomy (CEA) has been shown to have a durable effect in prevent-ing further events.

Complications ``

The most common complication from carotid intervention is cutaneous sensory or cranial nerve injury. However, the most dreaded complication is stroke due to embolization of

In cases where several hours have elapsed but recovery of viable tissue may still be possible, significant levels of lactic acid, potassium, and other harmful agents may be released into the circulation during revascularization. Pretreatment of the patient with sodium bicarbonate prior to reestab-lishing arterial flow is required. Surgery in the presence of thrombolytic agents and heparin carries a high risk of postoperative wound hematoma.

prognosis ``

There is a 10–25% risk of amputation with acute arterial occlusion caused by an embolus, and a 25% or higher in-hospital mortality rate. Prognosis for acute thrombotic occlusion of an atherosclerotic segment is generally much better because the collateral flow can maintain extremity viability. The longer term survival reflects the overall con-dition of the patient. In high-risk patients, an acute arterial occlusion suggests a dismal prognosis.

OCClusive CereBrOvasCular Disease

` `̀̀̀̀̀`̀̀̀`

sudden onset of weakness and numbness of an ` `̀̀̀̀̀`̀̀̀`

extremity, aphasia, dysarthria, or unilateral blind-ness (amaurosis fugax).

Bruit heard loudest in the mid neck.` `̀̀̀̀̀`̀̀̀`



Unlike the other vascular territories, symptoms of occlu-sive cerebrovascular disease are predominantly due to emboli. Transient ischemic attacks (TIAs) are the result of small emboli, and the risk of additional emboli causing permanent deficits is high. One-third of all strokes may be due to emboli. In the absence of atrial fibrillation, approxi-mately 90% of these emboli originate from the proximal internal carotid artery, an area uniquely prone to the devel-opment of atherosclerosis. Lesions in the proximal great vessels of the aortic arch and the common carotid are far less common. Intracranial atherosclerotic lesions are uncommon in the West but are the most common location of cerebrovascular disease in China.

Clinical Findings``


Generally, the symptoms of a TIA last only a few minutes but may continue up to 24 hours. The most common lesions are in the cortex with both motor and sensory involvement. Emboli to the retinal artery cause unilateral blindness which, when transient, is termed “amaurosis fugax.” Posterior circulation symptoms referable to the brainstem, cerebellum, and visual regions of the brain are due to atherosclerosis of the vertebral basilar systems and are much less common.


for patients with cerebrovascular disease regardless of planned intervention.

When to refer``

Asymptomatic or symptomatic patients with a carotid stenosis of > 80% and patients with carotid stenosis of > 50% stenosis with symptoms of a TIA or stroke should be referred to a vascular specialist.

Bonati LH et al; CAVATAS Investigators. Long-term risk of carotid restenosis in patients randomly assigned to endovas-cular treatment or endarterectomy in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): long-term follow-up of a randomized trial. Lancet Neurol. 2009 Oct;8(10):908–17. [PMID: 19717347]

Brott TG et al; CREST Investigators. Stenting versus endarterec-tomy for treatment of carotid-artery stenosis. N Engl J Med. 2010 Jul 1;363(1):11–23. [PMID: 20505173]

Hussain MS et al. Symptomatic delayed reocclusion after initial successful revascularization in acute ischemic stroke. J Stroke Cerebrovasc Dis. 2010 Jan;19(1):36–9. [PMID: 20123225]

International Carotid Stenting Study investigators; Ederle J et al. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial. Lancet. 2010 Mar 20;375(9719):985–97. [PMID: 20189239]

Zeebregts CJ. Carotid artery stenting: a 2009 update. Curr Opin Cardiol. 2009 Nov;24(6):528–31. [PMID: 19638930]

visCeral arTery insuFFiCienCy (intestinal angina)

` `̀̀̀̀̀`̀̀̀`

severe postprandial abdominal pain. ` `̀̀̀̀̀`̀̀̀`

Weight loss with a “fear of eating.”` `̀̀̀̀̀`̀̀̀`

acute mesenteric ischemia: severe abdominal pain ` `̀̀̀̀̀̀`̀̀`

yet minimal findings on physical examination.

E ssEnT ials of D iagnos is


Acute visceral artery insufficiency results from either embolic occlusion or primary thrombosis of at least one major mesenteric vessel. Ischemia can also result from non-occlusive mesenteric vascular insufficiency, which is gen-erally seen in patients with low flow states, such as congestive heart failure, or hypotension. A chronic syndrome occurs when there is adequate perfusion for the viscera at rest but ischemia occurs with severe abdominal pain when flow demands increase with feeding. Because of the rich collat-eral network in the mesentery, generally at least two of the three major visceral vessels (celiac, superior mesenteric, inferior mesenteric arteries) are affected before symptoms develop. Ischemic colitis, a variant of mesenteric ischemia, usually occurs in the distribution of the inferior mesenteric artery. The intestinal mucosa is the most sensitive to isch-emia and will slough if underperfused. The clinical presen-tation is similar to inflammatory bowel disease. Ischemic colitis can occur after aortic surgery, particularly aortic aneurysm resection or aortofemoral bypass for occlusive

plaque material during the procedure. The American Heart Association has recommended upper limits of acceptable combined morbidity and mortality for these interventions: 3% for asymptomatic, 5% for those with TIAs, and 7% for patients with previous stroke. Results that do not match these guidelines will jeopardize the therapeutic benefit of carotid intervention.

a. Carotid endarterectomy

In addition to stroke risk, CEA carries an 8% risk of tran-sient cranial nerve injury (usually the vagus or hypoglossal nerve) and 1–2% risk of permanent deficits. There is also the risk of postoperative neck hematoma, which can cause acute compromise of the airway. Coronary artery disease exists as a comorbidity in most of these patients. Myocardial infarction rates after CEA are approximately 5%.

B. angioplasty and stenting

Carotid angioplasty and stenting has been advocated as an alternative to CEA. Carotid angioplasty and stenting offers the advantage of avoidance of both cranial nerve injury and neck hematoma. However, emboli are more common during carotid angioplasty and stenting in spite of the use of embolic protection devices during the procedure. The International Carotid Stenting Study showed increased stroke rates with carotid angioplasty and stenting in symp-tomatic patients while the Carotid Revascularization Endarterectomy versus Stent Trial (CREST) showed similar overall morbidity with higher myocardial infarction rates with CEA and higher stroke rates with carotid angioplasty and stenting.

C. recurrent Carotid stenosis

Scarring of the arterial wall at the site of the intervention after both angioplasty and endarterectomy may create recurrent stenosis. These lesions tend to be less embolo-genic, and treatment need not be as aggressive as for pri-mary disease. The cranial nerve risk for these patients may be higher with repeat endarterectomy than with angio-plasty of the narrowed segment.

prognosis``

Prognosis for patients with carotid stenosis who have had a TIA or small stroke is poor without treatment; 25% of these patients will have a stroke with most of the events occurring in the first year of follow-up. Patients with carotid stenosis without symptoms have an annual stroke rate of just over 2% even with risk factor modification and antiplatelet agents. Symptomatic patients most likely have unstable plaques with ulceration or recent plaque enlarge-ment. Prospective ultrasound screening is recommended in asymptomatic patients because approximately 10% of asymptomatic patients have evidence of plaque progres-sion in a given year. Concomitant coronary artery disease is common and is an important factor in these patients both for perioperative risk and long-term prognosis. Aggressive risk factor modification should be prescribed


circulation becomes well established. The patient must be monitored closely for evidence of perforation, which will require resection.

prognosis``

The combined morbidity and mortality rates are 10–15% from surgical intervention in these debilitated patients. However, without intervention both acute and chronic intestinal ischemia are uniformly fatal. Adequate collateral circulation usually develops in those who have ischemic colitis, and the prognosis for this entity is better than chronic intestinal ischemia.

When to refer``

Any patient in whom there is a suspicion of intestinal ischemia should be referred for imaging and possible intervention.

Acosta S. Epidemiology of mesenteric vascular disease: clinical implications. Semin Vasc Surg. 2010 Mar;23(1):4–8. [PMID: 20298944]

Acosta S et al. Clinical implications for the management of acute thromboembolic occlusion of the superior mesenteric artery: autopsy findings in 213 patients. Ann Surg. 2005 Mar;241(3):516–22. [PMID: 15729076]

Cangemi JR et al. Intestinal ischemia in the elderly. Gastroenterol Clin North Am. 2009 Sep;38(3):527–40. [PMID: 19699412]

aCuTe MesenTeriC vein OCClusiOn

The hallmarks of acute mesenteric vein occlusion are post-prandial pain and evidence of a hypercoagulable state. Acute mesenteric vein occlusion presents similarly to the arterial occlusive syndromes but is much less common. Patients at risk include those with a systemic hypercoagu-lable state, such as that observed with paroxysmal nocturnal hemoglobinuria or protein C, protein S, antithrombin defi-ciencies, or the JAK2 mutation. These lesions are difficult to treat surgically, and thrombolysis is the mainstay of therapy. Aggressive long-term anticoagulation is required for these patients.

NONAtherOsclerOtic VAscUlAr DiseAse

THrOMBOanGiiTis OBliTerans (Buerger Disease)

` `̀̀̀̀̀`̀̀̀`

Typically occurs in male cigarette smokers.` `̀̀̀̀̀`̀̀̀`

Distal extremities involved with severe ischemia, ` `̀̀̀̀̀`̀̀̀`

progressing to tissue loss.

Thrombosis of the superficial veins may occur.` `̀̀̀̀̀`̀̀̀`

amputation will be necessary unless the patient ` `̀̀̀̀̀`̀̀̀`

stops smoking.


disease, when there is sudden reduction in blood flow to the inferior mesenteric artery.

Clinical Findings``


1. acute intestinal ischemia—Patients with primary visceral arterial thrombosis often give an antecedent history consistent with chronic intestinal ischemia. The key finding with acute intestinal ischemia is severe, steady epigastric and periumbilical pain with minimal or no findings on physical examination of the abdomen because the visceral peritoneum is severely ischemic or infarcted and the parietal peritoneum is not involved. A high white cell count, lactic acidosis, hypotension, and abdominal distention may aid in the diagnosis.

2. Chronic intestinal ischemia—Patients are generally over 45 years of age and may have evidence of atheroscle-rosis in other vascular beds. Symptoms consist of epigastric or periumbilical postprandial pain lasting 1–3 hours. To avoid the pain, patients limit food intake and may develop a fear of eating. Weight loss is universal.

3. ischemic colitis—Characteristic symptoms are left lower quadrant pain and tenderness, abdominal cramping, and mild diarrhea, which is often bloody.

B. imaging and Colonoscopy

In patients with acute or chronic intestinal ischemia, a CTA or MRA can demonstrate narrowing of the proximal visceral vessels. In acute intestinal ischemia from a nonoc-clusive low flow state, angiography is needed to display the typical “pruned tree” appearance of the distal visceral vas-cular bed. Ultrasound scanning of the mesenteric vessels may show proximal obstructing lesions in laboratories that have experience with this technique.

In patients with ischemic colitis, colonoscopy may reveal segmental ischemic changes, most often in the rectal sigmoid and splenic flexure where collateral circulation may be poor.

Treatment ``

A high suspicion of acute intestinal ischemia dictates immediate exploration to determine bowel viability. If the bowel remains viable, bypass can be done from the aorta to the celiac and the superior mesentery artery. In cases where bowel viability is questionable or bowel resection will be required, the bypass can be done with autologous vein, or with PTFE. There is a surprisingly low incidence of graft infection in these cases.

In chronic intestinal ischemia, angioplasty and stent-ing of the proximal vessel may be beneficial depending on the anatomy of the stenosis. Should an endovascular solu-tion not be available, an aorto-visceral artery bypass is the preferred management. The long-term results are highly durable. Visceral artery endarterectomy is reserved for cases with multiple lesions where bypass would be difficult.

The mainstay of treatment of ischemic colitis is main-tenance of blood pressure and perfusion until collateral


Al Mheid I et al. Cell therapy in peripheral arterial disease. Angiology. 2008 Dec–2009 Jan;59(6):705–16. [PMID: 18818233]

Małecki R et al. Thromboangiitis obliterans in the 21st century—a new face of disease. Atherosclerosis. 2009 Oct;206(2):328–34. [PMID: 19269635]

ArteriAl ANeUrysms

aBDOMinal aOrTiC aneurysMs

` `̀̀̀̀̀`̀̀̀`

Most aortic aneurysms are asymptomatic until ` `̀̀̀̀̀`̀̀̀`

rupture.

abdominal aortic aneurysms measuring 5 cm are ` `̀̀̀̀̀`̀̀̀`

palpable in 80% of patients.

Back or abdominal pain with aneurysmal tender-` `̀̀̀̀̀`̀̀̀`

ness may precede rupture.

Rupture is catastrophic; hypotension; excruciating ` `̀̀̀̀̀`̀̀̀`

abdominal pain that radiates to the back.



Dilatation of the infrarenal aorta is a normal part of aging. The aorta of a healthy young man measures approximately 2 cm. An aneurysm is considered present when the aortic diameter exceeds 3 cm, but aneurysms rarely rupture until their diameter exceeds 5 cm. Abdominal aortic aneurysms are found in 2% of men over 55 years of age; the male to female ratio is 4:1. Ninety percent of abdominal atheroscle-rotic aneurysms originate below the renal arteries. The aneurysms usually involve the aortic bifurcation and often involve the common iliac arteries.

Inflammatory aneurysms are an unusual variant. These have an inflammatory peel (similar to the inflammation seen with retroperitoneal fibrosis) that surrounds the aneurysm and encases adjacent retroperitoneal structures, such as the duodenum and, occasionally, the ureters.

Clinical Findings``


1. asymptomatic—Although 80% of 5-cm infrarenal aneurysms are palpable on routine physical examination, most aneurysms are discovered as incidental findings on ultrasound or CT imaging during the evaluation of unre-lated abdominal symptoms.

2. symptomatic—

A. Pain—Aneurysmal expansion may be accompanied by pain that is mild to severe midabdominal discomfort often radiating to the lower back. The pain may be constant or intermittent and is exacerbated by even gentle pressure on the aneurysm sack. Pain may also accompany inflamma-tory aneurysms. Most aneurysms have a thick layer of thrombus lining the aneurysmal sac, but embolization to the lower extremities is rarely seen.


Buerger disease is a segmental, inflammatory, and throm-botic process of the distal most arteries and occasionally veins of the extremities. Pathologic examination reveals arteritis in the affected vessels. The cause is not known but it is rarely seen in nonsmokers. Arteries most commonly affected are the plantar and digital vessels of the foot and lower leg. In advanced stages, the fingers and hands may become involved. While Buerger disease was once com-mon, its incidence has decreased dramatically.



Buerger disease may be initially difficult to differentiate from routine peripheral vascular disease, but in most cases, the lesions are on the toes and the patient is younger than 40 years old. The observation of superficial thrombophle-bitis may aid the diagnosis. Because the distal vessels are usually affected, intermittent claudication is not common with Buerger disease, but rest pain, particularly pain in the distal most extremity (ie, toes), is frequent. This pain often progresses to tissue loss and amputation, unless the patient stops smoking. The progression of the disease seems to be intermittent with acute and dramatic episodes followed by some periods of remission.

B. imaging

MRA or invasive angiography can demonstrate the obliteration of the distal arterial tree typical of Buerger disease.

Differential Diagnosis``

In atherosclerotic peripheral vascular disease, the onset of tissue ischemia tends to be less dramatic than in Buerger disease, and symptoms of proximal arterial involvement, such as claudication, predominate.

Symptoms of Raynaud disease may be difficult to dif-ferentiate from Buerger disease. Repetitive atheroemboli may also mimic Buerger disease and may be difficult to dif-ferentiate. It may be necessary to image the proximal arte-rial tree to rule out sources of arterial microemboli.

Treatment ``

Smoking cessation is the mainstay of therapy and will halt the disease in most cases. As the distal arterial tree is occluded, revascularization is not possible. Sympathectomy is rarely effective.

prognosis ``

If smoking cessation can be achieved, the outlook for Buerger disease may be better than in patients with prema-ture peripheral vascular disease. If smoking cessation is not achieved, then the prognosis is generally poor, with ampu-tation of both lower and upper extremities the eventual outcome.


patient to undergo urgent surgery. However, only half of those patients will survive. Endovascular repair is available for urgent aneurysm repair in most major vascular centers, with the results offering some improvement over open repair for these critically ill patients.

C. inflammatory aneurysm

The presence of peri-aortic inflammation (inflammatory aneurysm) is not an indication for surgical treatment, unless there is associated compression of retroperitoneal structures, such as the ureter. Interestingly, the inflamma-tion that encases an inflammatory aneurysm recedes after either endovascular or open surgical aneurysm repair.

D. assessment of Operative risk

Aneurysms appear to be a variant of systemic atherosclero-sis. Patients with aneurysms have a high rate of coronary disease. A 2004 trial demonstrated minimal value in addressing stable coronary artery disease prior to aneu-rysm resection. However, in patients with significant symptoms of coronary disease, the coronary disease should be treated first. Aneurysm resection should follow shortly thereafter because there is a significant increased risk in aneurysm rupture after the coronary procedures. In patients with concomitant carotid stenosis, repairing symptomatic (but not asymptomatic) carotid disease prior to aneurysm resection is beneficial.

e. Open surgical resection versus endovascular repair

In open surgical aneurysm repair, a graft is sutured to the non-dilated vessels above and below the aneurysm. This involves an abdominal incision, extensive dissection, and interruption of aortic blood flow. The mortality rate is low (2–5%) in centers that have a high volume for this proce-dure and when it is performed in good risk patients. Older, sicker patients may not tolerate the cardiopulmonary stresses of the operation. With endovascular repair, a stent-graft is used to line the aorta and exclude the aneurysm. The anatomic requirements to securely achieve aneurysm exclusion vary according to the performance characteris-tics of the specific stent-graft device. In general, successful attachment requires a segment of non-dilated aorta (neck) between the renal arteries and the aneurysm that is at least 15 mm in length, and device insertion requires the lumen of the iliac arteries to be at least 7 mm in diameter. Most studies have found that endovascular aneurysm repair offers patients reduced operative morbidity and mortality as well as shorter recovery periods. However, long-term survival is equivalent between the two techniques. Patients who undergo endovascular repair require more repeat interventions and need to be monitored postoperatively, since there is a 10–15% incidence of continued aneurysm growth post endovascular repair.

F. Thrombus in an aneurysm

The presence of thrombus within the aneurysm is not an indication for anticoagulation.

B. Rupture—The sudden escape of blood into the retro-peritoneal space causes severe pain, a palpable abdominal mass, and hypotension. Free rupture into the peritoneal cavity is a lethal event.


Even with a contained rupture, there may be little change in routine laboratory findings. In acute cases, the hemat-ocrit may be normal, since there has been no opportunity for hemodilution.

Patients with aneurysms may also have such cardiopul-monary diseases as coronary artery disease, carotid disease, renal impairment, and emphysema, which are typically seen in elderly men who smoke. Preoperative testing may indicate the presence of these comorbid conditions, which increase the risk of intervention.

C. imaging

Abdominal ultrasonography is the diagnostic study of choice for initial screening for the presence of an aneu-rysm. In approximately three-quarters of patients with aneurysms, curvilinear calcifications outlining portions of the aneurysm wall may be visible on plain films of the abdomen or back. CT scans provide a more reliable assess-ment of aneurysm diameter and should be done when the aneurysm nears the diameter threshold (5.5 cm) for treat-ment. Contrast-enhanced CT scans show the arteries above and below the aneurysm. The visualization of this vascula-ture is essential for planning repair.

Once an aneurysm is identified, routine follow-up with ultrasound will determine size and growth rate. The fre-quency of imaging depends on aneurysm size ranging from every 2 years for small (< 4 cm aneurysms) to every 6 months for aneurysms at or approaching 5 cm. When an aneurysm measures approximately 5 cm, a CTA with con-trast should be done to more accurately assess the size of the aneurysm and define the anatomy.

screening``

Data support the use of abdominal ultrasound to screen 65- to 74-year-old men, but not women, who have a history of smoking. Repeated screening does not appear to be needed if the aorta shows no enlargement.

Treatment ``

a. elective repair

In general, elective repair is indicated for aortic aneurysms ≥5.5 cm in diameter or aneurysms that have undergone rapid expansion (> 0.5 cm in 6 months). Symptoms such as pain or tenderness may indicate impending rupture and require urgent repair regardless of the aneurysm’s diameter.

B. aneurysmal rupture

A ruptured aneurysm is a lethal event. Approximately half the patients exsanguinate prior to reaching a hospital. In the remainder, bleeding may be temporarily contained in the retroperitoneum (contained rupture), allowing the


When to admit``

Patients with signs of aortic rupture require hospital admission.

De Bruin JL et al. Long-term outcome of open or endovascular repair of abdominal aortic aneurysm. N Engl J Med. 2010;362:1881–9. [PMID: 20484396]

Kim LG et al. Multicentre Aneurysm Screening Group. A sus-tained mortality benefit from screening for abdominal aortic aneurysm. Ann Intern Med. 2007 May 15;146(10):699–706. [PMID: 17502630]

Lederle FA et al; Open Versus Endovascular Repair (OVER) Veterans Affairs Cooperative Study Group. Outcomes follow-ing endovascular vs open repair of abdominal aortic aneu-rysm: a randomized trial. JAMA. 2009 Oct 14;302(14):1535–42. [PMID: 19826022]

Schanzer A et al. Predictors of abdominal aortic aneurysm sac enlargement post endovascular repair. Circulation. 2011 June 21:123(24):2848–55. [PMID: 21478500]

Schermerhorn ML et al. Endovascular vs. open repair of abdom-inal aortic aneurysms in the Medicare population. N Engl J Med. 2008 Jan 31;358(5):464–74. [PMID: 18234751]

Stanres BW et al. Management of ruptured abdominal aortic aneurysm in the endovascular era. J Vasc Surg. 2010 Jan:51(1):9–17. [PMID: 19883986]

United Kingdom EVAR Trial Investigators; Greenhalgh RM et al. Endovascular versus open repair of abdominal aortic aneu-rysm. N Engl J Med. 2010 May 20;362(20):1863–71. [PMID: 20382983]

THOraCiC aOrTiC aneurysMs

` `̀̀̀̀̀`̀̀̀`

Widened mediastinum on chest radiograph.` `̀̀̀̀̀`̀̀̀`

With rupture, sudden onset chest pain radiating to ` `̀̀̀̀̀`̀̀̀`

the back.



Most thoracic aortic aneurysms are due to atherosclerosis; syphilis is now a rare cause. Disorders of connective tissue and Ehlers-Danlos and Marfan syndromes also are rare causes but have important therapeutic implications. Traumatic, false aneurysms, caused by partial tearing of the aortic wall with deceleration injuries, may occur just beyond the origin of the left subclavian artery. Less than 10% of aortic aneurysms occur in the thoracic aorta.

Clinical Findings``


Most thoracic aneurysms are asymptomatic. When symp-toms occur, they depend largely on the size and the posi-tion of the aneurysm and its rate of growth. Substernal back or neck pain may occur. Pressure on the trachea, esophagus, or superior vena cava can result in the following symptoms and signs: dyspnea, stridor, or brassy cough; dysphagia; and edema in the neck and arms as well as dis-tended neck veins. Stretching of the left recurrent laryngeal

Complications ``

Myocardial infarction, the most common complication, occurs in up to 10% of patients who undergo open aneu-rysm repair. The incidence of myocardial infarction is substantially lower with endovascular repair. For routine infrarenal aneurysms, renal injury is unusual; however, when it does occur, or if the baseline creatinine is elevated, it is a significant complicating factor in the postoperative period. Respiratory complications are similar to those seen in most major abdominal surgery. Gastrointestinal hemor-rhage, even years after aortic surgeries, suggests the possi-bility of graft enteric fistula; the incidence of this complication is higher when the initial surgery is per-formed on an emergency basis.

prognosis``

The mortality rate for an open elective surgical resection is 1–5%, and the mortality rate for endovascular therapy is 0.5–2%. Of those who survive surgery, approximately 60% are alive at 5 years; myocardial infarction is the leading cause of death. The decision to repair aneurysms in high-risk patients has been made easier with the reduced periop-erative morbidity and mortality of the endovascular approach.

Mortality rates of untreated aneurysms vary with aneu-rysm diameter. The mortality rate among patients with large aneurysms has been defined as follows: 12% annual risk of rupture with an aneurysm ≥6 cm in diameter and a 25% annual risk of rupture in aneurysms of ≥7 cm diam-eter. In general, a patient with an aortic aneurysm ≥5.5 cm has a threefold greater chance of dying of a consequence of rupture of the aneurysm than of dying of the surgical resection.

At present, endovascular aneurysm repair may be less definitive than open surgical repair and requires close fol-low up with an imaging procedure. Device migration, component separation, limb thrombosis, or limb kinking are common reasons for repeat intervention. With com-plete exclusion of blood from the aneurysm sac, the pres-sure is lowered, which causes the aneurysm to shrink. An “endoleak” from the top or bottom of the graft (type 1) or through a graft defect (type 3) is associated with a persis-tent risk of rupture. Indirect leakage of blood through persistent lumbar and inferior mesenteric branches of the aneurysm (endoleak, type 2) produces an intermediate picture with somewhat reduced pressure in the sac, slow shrinkage, and low rupture risk. However, type 2 endoleak warrants close observation because aneurysm dilatation and rupture can occur.

When to refer``• Any patient with a 4 cm aortic aneurysm or larger

should be referred for imaging and assessment by a vascular specialist.

• Urgent referrals should be made if the patient com-plains of pain and gentle palpation of the aneurysm confirms that it is the source, regardless of the aneurys-mal size.


However, stable aneurysms can be followed with CT scan-ning. Saccular aneurysms, particularly those distal to the left subclavian artery and the descending thoracic aorta, have had good results with endovascular repair. Resection of large complex aneurysms of the aortic arch involves major technical issues and requires a skilled surgical team and should only be attempted in low-risk patients. Branched fenestrated technology for endovascular grafting is becom-ing widely available and holds promise for reduced morbid-ity and mortality.

When to refer``

Patients who are deemed to have a reasonable surgical risk with a 5–6 cm aneurysm should be considered for repair, particularly if the aneurysm involves the descending tho-racic aorta.

When to admit``

Any patient with chest or back pain with a known or sus-pected thoracic aorta aneurysm must be admitted to the hospital and undergo imaging studies to rule out the aneu-rysm as a cause of the pain.

Jonker FH et al. Meta-analysis of open versus endovascular repair for ruptured descending thoracic aortic aneurysm. J Vasc Surg. 2010 Apr;51(4):1026–32. [PMID: 20347700]

Jonker FH et al. Outcomes of endovascular repair of ruptured descending thoracic aortic aneurysms. Circulation. 2010 Jun 29;121(25):2718–23. [PMID: 20547930]

Park KH et al. Variation in the shape and length of the branches of a thoracoabdominal aortic stent graft: implications for the role of standard off-the-shelf components. J Vasc Surg. 2010 Mar;51(3):572–6. [PMID: 20045625]

Svensson LG et al; Society of Thoracic Surgeons Endovascular Surgery Task Force. Expert consensus document on the treat-ment of descending thoracic aortic disease using endovascu-lar stent-grafts. Ann Thorac Surg. 2008 Jan;85(1 Suppl):S1–41. [PMID: 18083364]

Torsello GB et al. Midterm results from the TRAVIATA registry: treatment of thoracic aortic disease with the Valiant stent graft. J Endovasc Ther. 2010 Apr;17(2):137–50. [PMID: 20426628]

peripHeral arTery aneursyMs

` `̀̀̀̀̀`̀̀̀`

Widened, prominent pulses.` `̀̀̀̀̀`̀̀̀`

acute leg or foot pain and paresthesias with loss ` `̀̀̀̀̀`̀̀̀`

of distal pulses.



Like aortic aneurysms, peripheral artery aneurysms are silent until critically symptomatic. However, unlike aortic aneurysms, the presenting manifestations are due to peripheral embolization and thrombosis. Popliteal artery aneurysms account for 70% of peripheral arterial aneu-rysms. Popliteal aneurysms may embolize repetitively over

nerve causes hoarseness. With aneurysms of the ascending aorta, aortic regurgitation may be present due to dilation of the aortic valve annulus. Rupture of a thoracic aneurysm is catastrophic because bleeding is rarely contained, allow-ing no time for emergent repair.

B. imaging

The aneurysm may be diagnosed on chest radiograph by the calcified outline of the dilated aorta. CT scanning is the modality of choice to demonstrate the anatomy and size of the aneurysm and to exclude lesions that can mimic aneu-rysms, such as neoplasms or substernal goiter. MRI can also be useful. Cardiac catheterization and echocardiogra-phy may be required to describe the relationship of the coronary vessels to an aneurysm of the ascending aorta.

Treatment``

Indications for repair depend on the location of dilation, rate of growth, associated symptoms, and overall condition of the patient. Aneurysms measuring 6 cm or larger may be considered for repair. Aneurysms of the descending tho-racic aorta are treated routinely by endovascular grafting. Repair of arch aneurysms should be undertaken only if there is a skilled surgical team with an acceptable record of outcomes for these complex procedures. The availability of thoracic aortic endograft technique for descending tho-racic aneurysms or experimental branched endovascular reconstructions for arch aneurysms (custom made grafts with branches to the vessels involved in the aneurysm) does not change the indications for aneurysm repair. Aneurysms that involve the proximal aortic arch or ascend-ing aorta represent particularly challenging problems. Open surgery is usually required; however, it carries sub-stantial risk of morbidity (including stroke, diffuse neuro-logic injury, and intellectual impairment) because interruption of arch blood flow is required.

Complications``

With the exception of endovascular repair for discrete sac-cular aneurysms of the descending thoracic aorta, the morbidity and mortality of thoracic repair is considerably higher than that for infra-renal abdominal aortic aneu-rysm repair. Paraplegia remains a devastating, complica-tion. Most large series report approximately 4–10% rate of paraplegia following endovascular repair of thoracic aortic aneurysms. The spinal arterial supply is segmental through intercostal branches of the aorta with variable degrees of intersegmental connection. Therefore, the more extensive the aneurysm, the greater is the risk of paraplegia with resection. Prior infrarenal abdominal aortic surgery, sub-clavian or internal iliac artery stenosis, and hypotension all increase the paraplegia risk. Involvement of the aortic arch also increases the risk of stroke, even when the aneurysm does not directly affect the carotid artery.

prognosis ``

Generally, degenerative aneurysms of the thoracic aorta will enlarge and require repair to prevent death from rupture.


suggests that immediate surgery is not imperative. Bypass is generally performed. Endovascular exclusion of the aneurysm can be done but is reserved for high-risk patients. Acute pseudoaneurysms of the femoral artery due to arterial punctures can be successfully treated using ultrasound-guided compression. Open surgery with pros-thetic interposition grafting is preferred for primary aneu-rysms of the femoral artery.

prognosis``

The long-term patency of bypass grafts for femoral and popliteal aneurysms is generally excellent but depends on the adequacy of the outflow tract. Late graft occlusion is less common than in similar surgeries for occlusive disease.

When to refer``

In addition to patients with symptoms of ischemia, any patient with a peripheral arterial aneurysm measuring 2 cm or with ultrasound evidence of thrombus within the aneurysm should be referred to prevent progression to limb-threatening ischemia.

Cross JE et al. Nonoperative versus surgical management of small (less than 3 cm), asymptomatic popliteal artery aneu-rysms. J Vasc Surg. 2011 Apr;53(4):1145–8. [PMID: 21439460]

aOrTiC DisseCTiOn

` `̀̀̀̀̀`̀̀̀`

sudden searing chest pain with radiation to the ` `̀̀̀̀̀`̀̀̀`

back, abdomen, or neck in a hypertensive patient.

Widened mediastinum on chest radiograph. ` `̀̀̀̀̀`̀̀̀`

Pulse discrepancy in the extremities. ` `̀̀̀̀̀`̀̀̀`

acute aortic regurgitation may develop.` `̀̀̀̀̀`̀̀̀`



Aortic dissection occurs when a spontaneous intimal tear develops and blood dissects into the media of the aorta. The tear probably results from the repetitive torque applied to the ascending and proximal descending aorta during the cardiac cycle; hypertension is an important component of this disease process. Type A dissection involves the arch proximal to the left subclavian artery, and type B dissection occurs in the proximal descending thoracic aorta typically just beyond the left subclavian artery. Dissections may occur in the absence of hypertension but abnormalities of smooth muscle, elastic tissue, or collagen are more common in these patients. Pregnancy, bicuspid aortic valve, and coarctation also are associated with increased risk of dissection.

Blood entering the intimal tear may extend the dissec-tion into the abdominal aorta, the lower extremities, the carotid arteries or, less commonly, the subclavian arteries.

time and occlude distal arteries. Due to the redundant parallel arterial supply to the foot, ischemia does not occur until a final embolus occludes flow. Approximately one-third of patients will require an amputation. To prevent limb loss, popliteal artery aneurysms should be repaired if > 2 cm in diameter or if lined with thrombus at any size.

Primary femoral artery aneurysms are much less com-mon. However, pseudoaneurysms of the femoral artery following arterial punctures for arteriography and cardiac catheterization occur with an incidence ranging from 0.05% to 6% of arterial punctures. Thrombosis and embo-lization are the main risks of femoral true or false aneu-rysms and, like popliteal aneurysms, should be repaired when > 2 cm in diameter.

Clinical Findings``


The patient may be aware of a pulsatile mass when the aneurysm is in the groin, but popliteal aneurysms are often undetected by the patient and clinician. Rarely, peripheral aneurysms may produce symptoms by compressing the local vein or nerve. The first symptom may be due to isch-emia of acute arterial occlusion. The symptoms range from sudden onset pain and paralysis to short distance claudica-tion that slowly lessens as collateral circulation develops. Symptoms from recurrent embolization to the leg are often transient, if they occur at all. Sudden ischemia may appear in a toe or part of the foot, followed by slow resolution, and the true diagnosis may be elusive. The onset of recurrent episodes of pain in the foot, particularly if accompanied by cyanosis, suggests embolization and requires investigation of the heart and proximal arterial tree.

Because popliteal pulses are somewhat difficult to pal-pate even in normal individuals, a particularly prominent or easily felt pulse is suggestive of aneurysm and should be investigated by ultrasound. Since popliteal aneurysms are bilateral in 60% of cases, the diagnosis of thrombosis of a popliteal aneurysm is often aided by the palpation of a pulsatile aneurysm in the contralateral popliteal space. Approximately 50% of patients with popliteal aneurysms have an aneurysmal abdominal aorta.

B. imaging studies

Duplex color ultrasound is the most efficient investigation to confirm the diagnosis of peripheral aneurysm, measure its size and configuration, and demonstrate mural throm-bus. MRA or CTA are required to define the aneurysm and local arterial anatomy for reconstruction. Arteriography is not recommended because mural thrombus reduces the apparent diameter of the lumen on angiography.

Treatment``

Surgery is indicated when an aneurysm is associated with any peripheral embolization, is > 2 cm, or a mural throm-bus is present. Immediate or urgent surgery is indicated when acute embolization or thrombosis has caused acute ischemia. Intra-arterial thrombolysis may be done in the setting of acute ischemia, if examination (light touch)


minimal pain; branch vessel occlusion of the lower extrem-ity can mimic arterial embolus.

Treatment ``

a. Medical

Aggressive measures to lower blood pressure should occur when an aortic dissection is suspected, even before the diagnostic studies have been completed. Treatment requires a simultaneous reduction of the systolic blood pressure to 100–120 mm Hg and pulse pressure. b-Blockers have the most desirable effect of reducing the left ventricular ejec-tion force that continues to weaken the arterial wall and should be first-line therapy. Labetalol, both an a- and b-blocker, lowers pulse pressure and achieve rapid blood pressure control. Give 20 mg over 2 minutes by intravenous injection. Additional doses of 40–80 mg intravenously can be given every 10 minutes (maximum dose 300 mg) until the desired blood pressure has been reached. Alternatively, 2 mg/min may be given by intravenous infusion, titrated to desired effect. In patients who have asthma, bradycardia, or other conditions that necessitate the patient’s reaction to b-blockers be tested, esmolol is a reasonable choice because of its short half-life. Give a loading dose of esmolol, 0.5 mg/kg over 1 minute followed by an infusion of 0.0025–0.02 mg/kg/min. Titrate the infusion to a goal heart rate of 60–70 beats/min. If b-blockade alone does not control the hypertension, nitroprusside may be added as follows: 50 mg of nitroprusside in 1000 mL of 5% dextrose and water, infused at a rate of 0.5 mL/min; the infusion rate is increased by 0.5 mL every 5 minutes until adequate control of the pressure has been achieved. In patients with bron-chial asthma, while there are no data supporting the use of the calcium-channel antagonists, diltiazem and verapamil are potential alternatives to treatment with b-blocking drugs. Morphine sulfate is the appropriate drug to use for pain relief. Long-term medical care of patients should include b-blockers in their antihypertensive regimen.

B. surgical intervention

Urgent surgical intervention is required for all type A dis-sections. If a skilled cardiovascular team is not available, the patient should be transferred to an appropriate facility. The procedure involves grafting and replacing the diseased portion of the arch and brachiocephalic vessels as neces-sary. Replacement of the aortic valve may be required with reattachment of the coronary arteries.

Urgent surgery is required for type B dissections if there is aortic branch compromise resulting in malperfu-sion of the renal, visceral, or extremity vessels. While endo-vascular therapy may have a role in the treatment of complications following type B dissection, there is no evi-dence to support the early endovascular intervention of uncomplicated type B dissections.

prognosis & Follow-up ``

The mortality rate for untreated type A dissections is approx-imately 1% per hour for 72 hours and over 90% at 3 months. Mortality is also extremely high for untreated complicated

Both absolute pressure levels and the pulse pressure are important in propagation of dissection. The aortic dissec-tion is a true emergency and requires immediate control of blood pressure to limit the extent of the dissection. With type A dissection, which has the worse prognosis, death may occur within hours, usually due to rupture of the dis-section into the pericardial sac. Rupture into the pleural cavity is also possible. The intimal/medial flap of the aortic wall created by the dissection may occlude major aortic branches, resulting in ischemia of the brain, intestines, kidney, or lower extremities. Patients whose blood pressure is controlled and who survive the acute episode without complications may have long-term survival without surgi-cal treatment.

Clinical Findings``


Severe persistent chest pain of sudden onset radiating down the back or possibly into the anterior chest is charac-teristic. Radiation of the pain into the neck may also occur. The patient is usually hypertensive. Syncope, hemiplegia, or paralysis of the lower extremities may occur. Intestinal ischemia or renal insufficiency may develop. Peripheral pulses may be diminished or unequal. A diastolic murmur may develop as a result of a dissection in the ascending aorta close to the aortic valve, causing valvular regurgita-tion, heart failure, and cardiac tamponade.

B. electrocardiographic Findings

Left ventricular hypertrophy from long-standing hyperten-sion is often present. Acute changes suggesting myocardial ischemia do not develop unless dissection involves the coronary artery ostium. Classically, inferior wall abnor-malities predominate since dissection leads to compromise of the right rather than the left coronary artery. In some patients, the ECG may be completely normal.

C. imaging

A multiplanar CT scan is the immediate diagnostic imag-ing modality of choice; clinicians should have a low thresh-old for obtaining a CT scan in any hypertensive patient with chest pain and equivocal findings on ECG.

The CT scan should include both the chest and abdo-men to fully delineate the extent of the dissected aorta. MRI is an excellent imaging modality for chronic dissec-tions, but in the acute situation, the longer imaging time and the difficulty of monitoring patients in the MRI scanner make the CT scan preferable. Chest radiographs may reveal an abnormal aortic contour or widened supe-rior mediastinum. Although transesophageal echocar-diography (TEE) is an excellent diagnostic imaging method, it is generally not readily available in the acute setting.

Differential Diagnosis ``

Aortic dissection is most commonly misdiagnosed as myo-cardial infarction or other causes of chest pain such as pulmonary embolization. Dissections may occur with


lifting are contributing factors, but the highest incidence occurs in women after pregnancy. Varicosities develop in 15% of all adults.

The greater saphenous vein and its tributaries are most commonly involved, but the short saphenous vein (poste-rior lower leg) may also be affected. Distention of the vein prevents the valve leaflets from coapting, creating incompe-tence. Thus, dilation at any point along the vein leads to increased pressure and distention of the vein segment below that valve, which in turn causes progressive failure of the next lower valve and progressive venous reflux. Perforating veins that connect the deep and superficial systems may become incompetent, allowing blood to reflux into the superficial veins from the deep system through the incom-petent perforators and increasing venous pressure and distention.

Secondary varicosities can develop as a result of obstructive changes and valve damage in the deep venous system following thrombophlebitis, or rarely as a result of proximal venous occlusion due to neoplasm or fibro-sis. Congenital or acquired arteriovenous fistulas or venous malformations are also associated with varicosi-ties and should be considered in young patients with varicosities.

Clinical Findings``


Symptom severity is not correlated with the number and size of the varicosities; extensive varicose veins may pro-duce no subjective symptoms, whereas minimal varicosi-ties may produce many symptoms. Dull, aching heaviness or a feeling of fatigue of the legs brought on by periods of standing is the most common complaint.

Clinicians must be careful to identify symptoms of occlusive peripheral vascular disease, such as intermittent claudication and coldness of the feet, since occlusive arte-rial disease is usually a contraindication to the operative treatment of varicosities distal to the knee. Itching from a venous stasis dermatitis may occur either above the ankle or directly overlying large varicosities.

Dilated, tortuous veins beneath the skin in the thigh and leg are generally visible upon standing, although in very obese patients palpation may be necessary to detect their presence and location. Some swelling is common but secondary tissue changes may be absent even in extensive varicosities. However, if the varicosities are of long dura-tion, brownish pigmentation and thinning of the skin above the ankle may be present. The presence of a bruit or a thrill is useful in making the diagnosis of an associated arteriovenous fistula.

B. imaging

The identification of the source of venous reflux that feeds the symptomatic veins is necessary for effective surgical treatment. Duplex ultrasonography by a technician experi-enced in the diagnosis and localization of venous reflux is the test of choice for planning therapy. In most cases, reflux will arise from the greater saphenous vein.

type B dissections. The surgical and endovascular options for these patients also have significant morbidity and mortality. They are technically demanding and require an experienced team to achieve perioperative mortalities of < 10%. Patients with uncomplicated type B dissections whose blood pressure is controlled and who survive the acute episode without com-plications may have long-term survival without surgical treatment. Aneurysmal enlargement of the false lumen may develop in these patients despite adequate antihypertensive therapy. Yearly CT scans are required to monitor the size of the aneurysm. Indications for repair are determined by size (≥ 6 cm), similar to undissected thoracic aneurysms. Endovascular covering of the intimal tear in the acute setting may prevent this complication, but initial trials on the rou-tine endovascular treatment of type B dissections have not shown an advantage for early intervention and therefore cannot be widely endorsed at this time.

When to admit``

Any dissection involving the aortic arch (type A) should be immediately repaired. Acute type B dissections require repair only when there is evidence of rupture or major branch occlusion.

Feezor RJ et al. Early outcomes after endovascular management of acute, complicated type B aortic dissection. J Vasc Surg. 2009 Mar;49(3):561–6. [PMID: 19268759]

Kim KM et al. Aortic remodeling, volumetric analysis, and clini-cal outcomes of endoluminal exclusion of acute complicated type B thoracic aortic dissections. J Vasc Surg. 2011 Aug;54(2):316–24. [PMID: 21819922]

Litmanovich D et al. CT and MRI in diseases of the aorta. AJR Am J Roentgenol. 2009 Oct;193(4):928–40. [PMID: 19770313]

Nienaber CA et al. Randomized comparison of strategies for type B aortic dissection: the INvestigation of STEnt Grafts in Aortic Dissection (INSTEAD) trial. Circulation. 2009 Dec 22;120(25):2519–28. [PMID: 19996018]

VeNOUs DiseAses

variCOse veins

` `̀̀̀̀̀`̀̀̀`

Dilated, tortuous superficial veins in the lower ` `̀̀̀̀̀`̀̀̀`

extremities.

May be asymptomatic or associated with aching ` `̀̀̀̀̀`̀̀̀`

discomfort or pain.

often hereditary.` `̀̀̀̀̀`̀̀̀`

increased frequency after pregnancy.` `̀̀̀̀̀`̀̀̀`



Varicose veins develop in the lower extremities. Periods of high venous pressure related to prolonged standing or heavy


to volume overload in this setting, which will resolve with correction of the superficial reflux.

C. Compression sclerotherapy

Sclerotherapy to obliterate and produce permanent fibrosis of the involved veins is generally reserved for the treatment of small varicose veins < 4 mm in diameter. Use of foam sclerotherapy can allow treatment of larger veins, although systemic embolization of the foam sclerosant may be a concern. The injection of the sclerosing solution into the varicosed vein is followed by a period of compression of the segment, resulting in obliteration of the vein. Complications such as phlebitis, tissue necrosis, or infec-tion may occur, and vary in incidence with the skill of the clinician.

prognosis``

Surgical correction of venous insufficiency (reflux) and excision of varicose veins provide excellent results. The 5-year success rate (as defined as lack of pain and recurrent varicosities) is 85–90%. Simple excision (phlebectomy) or injection sclerotherapy without correction of reflux is asso-ciated with higher rates of recurrence. Even after adequate treatment, secondary tissue changes, such as lipodermo-sclerosis, may persist.

When to refer``• Absoluteindicationsforreferralforsaphenousablation

include phlebitis and bleeding.

• Pain and cosmetic concerns are responsible for themajority of referrals for ablation.

Figueiredo M et al. Results of surgical treatment compared with ultrasound-guided foam sclerotherapy in patients with vari-cose veins: a prospective randomised study. Eur J Vasc Endovasc Surg. 2009 Dec;38(6):758–63. [PMID: 19744867]

Rasmussen LH et al. Randomised clinical trial comparing endovenous laser ablation with stripping of the great saphenous vein: clinical outcome and recurrence after 2 years. Eur J Vasc Endovasc Surg. 2010 May;39(5):630–5. [PMID: 20064730]

Subramonia S et al. Randomized clinical trial of radiofrequency ablation or conventional high ligation and stripping for great saphenous varicose veins. Br J Surg. 2010 Mar;97(3):328–36. [PMID: 20035541]

superFiCial venOus THrOMBOpHleBiTis

` `̀̀̀̀̀`̀̀̀`

induration, redness, and tenderness along a ` `̀̀̀̀̀`̀̀̀`

superficial vein, usually the saphenous vein.

induration, redness, and tenderness at the site of ` `̀̀̀̀̀`̀̀̀`

a recent intravenous line.

significant swelling of the extremity may not be ` `̀̀̀̀̀`̀̀̀`

seen.



Primary varicose veins should be differentiated from those secondary to chronic venous insufficiency of the deep sys-tem of veins with extensive swelling, fibrosis, pigmentation, and ulceration of the distal lower leg (the postphlebitic syndrome). Pain or discomfort secondary to arthritis, radiculopathy, or arterial insufficiency should be distin-guished from symptoms associated with coexistent vari-cose veins. In adolescent patients with varicose veins, imaging of the deep venous system is important to exclude a congenital malformation or atresia of the deep veins. Surgical treatment of varicose veins in these patients is contraindicated because the varicosities may play a signifi-cant role in venous drainage of the limb.

Complications``

Thrombophlebitis within a varicose vein is uncommon. This presents as subacute to acute localized pain and pal-pable hardness at the site of the phlebitis. The process is self-limiting, has a low risk of embolization, and usually resolves within weeks. Rarely, the phlebitis extends to involve the greater saphenous vein. Predisposing condi-tions for thrombophlebitis include pregnancy, local trauma, or prolonged periods of sitting.

In older patients, superficial varicosities may bleed with even minor trauma. The amount of bleeding can be alarm-ing as the pressure in the varicosity is high.

Treatment``

a. nonsurgical Measures

Nonsurgical treatment is effective. Elastic graduated com-pression stockings (medium or heavy weight) give external support to the veins. These stockings may be useful in early varicosities to prevent progression of disease. When elastic stockings worn during standing are combined with eleva-tion of the legs when possible, good control can be main-tained and the development of complications can often be avoided. This approach may be used in elderly patients, in those who refuse or wish to defer surgery, and in those with mild asymptomatic varicosities.

B. surgical Measures

Treatment with endovenous ablation (with either radio-frequency or laser) or, less commonly, with greater saphenous vein stripping is very effective for reflux aris-ing from the greater saphenous vein. Less common sources of reflux include the lesser saphenous vein (for varicosities in the posterior calf), and nonsaphenous incompetent perforator veins arising directly from the deep venous system in the thigh. Correction of reflux is performed at the same time as excision of the symptomatic varicose veins. Phlebectomy without correction of reflux results in a high rate of recurrent varicosities, as the uncor-rected reflux progressively dilates adjacent veins. Concurrent reflux detected by ultrasonography in the deep system is not a contraindication to treatment of superficial reflux because the majority of deep vein dilatation is secondary


Septic superficial thrombophlebitis is an intravascular abscess and requires urgent treatment with heparin (see Table 14–15) to limit additional thrombus formation and antibiotics (eg, vancomycin, 15 mg/kg intravenously every 12 hours plus ceftriaxone, 1 g intravenously every 24 hours). Surgical excision of the involved vein may also be necessary to control the infection. Staphylococcus aureus is the most common pathogen. If cultures are positive, therapy should be continued for 7–10 days or for 4–6 weeks if complicat-ing endocarditis cannot be excluded. Other organisms, including fungi, may also be responsible.

prognosis``

With spontaneous thrombophlebitis, the course is gener-ally benign and brief. The prognosis depends on the under-lying pathologic process. In patients with phlebitis secondary to varicose veins, recurrent episodes are likely unless correction of the underlying venous reflux and exci-sion of varicosities is done. In contrast, the mortality from septic thrombophlebitis is 20% or higher and requires aggressive treatment. However, if the involvement is local-ized, the mortality is low and prognosis is excellent with early treatment.

van Weert H et al. Spontaneous superficial venous thrombophle-bitis: does it increase risk for thromboembolism? A historic follow-up study in primary care. J Fam Pract. 2006 Jan;55(1): 52–7. [PMID: 16388768]

CHrOniC venOus insuFFiCienCy

` `̀̀̀̀̀`̀̀̀`

History of prior DVT or leg injury.` `̀̀̀̀̀`̀̀̀`

Edema, stasis (brawny) skin pigmentation, subcu-` `̀̀̀̀̀`̀̀̀`

taneous liposclerosis in the lower leg.

large ulcerations at or above the ankle are com-` `̀̀̀̀̀`̀̀̀`

mon (stasis ulcers).



Chronic venous insufficiency can result from changes secondary to acute deep venous thrombophlebitis (see Chapter 14), although a definite history of phlebitis is not obtainable in about 25% of these patients. There may be a history of leg trauma. Obesity is often a complicating factor. Chronic venous insufficiency also may occur in association with superficial venous reflux and varicose veins or as a result of neoplastic obstruction of the pelvic veins or congenital or acquired arteriovenous fistula.

The basic pathology is caused by valve leaflets that do not coapt because they are either thickened and scarred (the post-thrombotic syndrome) or in a dilated vein and are therefore functionally inadequate. This results in an abnormally high hydrostatic force transmitted to the sub-cutaneous veins and tissues of the lower leg. The resulting


Short-term venous catheterization of superficial arm veins as well as the use of longer term peripherally inserted cen-tral catheter (PICC) lines are the most common cause of superficial thrombophlebitis. Intravenous catheter sites should be observed daily for signs of local inflammation and should be removed if a local reaction develops in the vein. Serious thrombotic or septic complications can occur if this policy is not followed.

Superficial thrombophlebitis may occur spontaneously, as in pregnant or postpartum women or in individuals with varicose veins or thromboangiitis obliterans; or it may be associated with trauma, as in the case of a blow to the leg or following intravenous therapy with irritating solu-tions. It also may be a manifestation of systemic hyperco-agulability secondary to abdominal cancer such as carcinoma of the pancreas and may be the earliest sign of these conditions. Superficial thrombophlebitis may be associated with occult deep venous thrombosis (DVT) in about 20% of cases. Pulmonary emboli are exceedingly rare and occur from an associated DVT. (See Chapters 9 and 14 for discussion on Deep Venous Thrombosis.)

Clinical Findings``

In spontaneous superficial thrombophlebitis, the greater saphenous vein is most often involved. The patient usually experiences a dull pain in the region of the involved vein. Local findings consist of induration, redness, and tender-ness along the course of a vein. The process may be local-ized, or it may involve most of the long saphenous vein and its tributaries. The inflammatory reaction generally sub-sides in 1–2 weeks; a firm cord may remain for a much longer period. Edema of the extremity is uncommon.

Localized redness and induration at the site of a recent intravenous line requires urgent attention. Proximal exten-sion of the induration and pain with chills and high fever suggest septic phlebitis and requires urgent treatment.


The linear rather than circular nature of the lesion and the distribution along the course of a superficial vein serve to differentiate superficial phlebitis from cellulitis, erythema nodosum, erythema induratum, panniculitis, and fibrositis. Lymphangitis and deep thrombophlebitis must also be considered.

Treatment``

For spontaneous thrombophlebitis if the process is well localized and not near the saphenofemoral junction, local heat, and nonsteroidal anti-inflammatory medications are usually effective in limiting the process. If the induration is extensive or is progressing toward the saphenofemoral junction (leg) or cephalo-axillary junction (arm), ligation and division of the vein at the junction of the deep and superficial veins is indicated.

Anticoagulation therapy is usually not required unless the disease is rapidly progressing or there is concern for extension into the deep system.


prevention``

Irreversible tissue changes and associated complications in the lower legs can be minimized through early and aggres-sive anticoagulation of acute DVT to minimize the valve damage and by prescribing compression stockings if chronic edema develops after the DVT has resolved. Catheter-directed thrombolysis or mechanical thrombec-tomy of acute DVT may be of greater value than simple anticoagulants in preventing post-thrombotic syndrome and chronic venous insufficiency.

Treatment``

a. General Measures

Well-fitting, graduated compression stockings worn from the mid foot to just below the knee during the day and evening are the mainstays of treatment and is usually suf-ficient. When it is not, additional measures, such as avoid-ance of long periods of sitting or standing and intermittent elevations of the involved leg and sleeping with the legs kept above the level of the heart, may be necessary to con-trol the swelling. Pneumatic compression of the leg, which can pump the fluid out of the leg, is used in cases refractory to the above measures.

B. ulceration

As the primary pathology is edema, healing of the ulcer will not occur until the edema is controlled. A lesion can often be treated on an ambulatory basis by means of a semi-rigid gauze boot made with Unna paste (Gelocast, Medicopaste) or a multi-layer compression (such as Profore) and applied to the leg after much of the swelling has been reduced by a period of elevation. The boot must be changed every 2–3 days, depending on the amount of drainage from the ulcer. The ulcer, tendons, and bony prominences must be adequately padded. As an alternative and after the ulcer has healed, elastic stockings with graduated compression below the knee are used in an effort to prevent recurrent edema and ulceration. If compression stockings are used with ulcers, an absorbent dressing must be applied under the stocking as the wounds can leak large volumes of fluid. The pumping action of the calf muscles on the blood flow out of the lower extremity is enhanced by a circumferential nonelastic bandage on the ankle and lower leg. Home com-pression therapy with a pneumatic compression device is also effective at reducing edema, but many patients have severe pain with the “milking” action of the pump device. Some patients will require admission for complete bed rest and leg elevation to achieve ulcer healing.

C. Correction of superficial reflux

Incompetent (refluxing) perforator veins that feed the area of ulceration can be treated with percutaneous means (radiofrequency ablation or endovenous laser treatment) to help decrease the venous pressure in the area of ulceration and promote healing. Venous valvular reconstructive surgery is under investigation. Where there is substantial obstruction of the deep venous system, superficial varicosities supply the venous return and they should not be removed.

edema results in dramatic and deleterious secondary changes. The stigmata of chronic venous insufficiency include fibrosis of the subcutaneous tissue and skin, pig-mentation of skin (hemosiderin taken up by the dermal macrophages) and, later, ulceration which is extremely slow to heal. Itching may precipitate the formation of ulceration or local wound cellulitis. Dilation of the super-ficial veins may occur, leading to varicosities. Whereas pri-mary varicose veins with no abnormality of the deep venous system may be associated with some similar changes, the edema is more pronounced in the post-thrombotic extremities, and the secondary changes are more extensive and debilitating.

Clinical Findings``


Progressive pitting edema of the leg (particularly the lower leg) is the primary presenting symptom. Secondary changes in the skin and subcutaneous tissues develop over time. The usual symptoms are itching, a dull discomfort made worse by periods of standing, and pain if an ulceration is present. The skin at the ankle is usually taut from swelling, shiny, and a brownish pigmentation (hemosiderin) often devel-ops. If the condition is long-standing, the subcutaneous tissues become thick and fibrous. Ulcerations may occur, usually just above the ankle, on the medial or anterior aspect of the leg. Healing results in a thin scar on a fibrotic base that often breaks down with minor trauma or further bouts of leg swelling. Varicosities may appear that are asso-ciated with incompetent perforating veins. Cellulitis, which is often difficult to distinguish from the hemosiderin pig-mentation, may be diagnosed by blanching erythema.

B. imaging

Patients with post-thrombotic syndrome or signs of chronic venous insufficiency should undergo duplex ultrasonogra-phy to determine whether superficial reflux is present and to evaluate the degree of deep reflux and obstruction.


Patients with congestive heart failure, chronic kidney disease, or decompensated liver disease may have bilateral edema of the lower extremities. Swelling from lymphedema may be unilateral, but varicosities are absent. Edema from these causes pits easily and brawny discoloration is rare. Lipedema is a disorder of adipose tissue that occurs almost exclusively in women, is bilateral and symmetric, and is characterized by stopping at a distinct line just above the ankles.

Primary varicose veins may be difficult to differentiate from the secondary varicosities that often develop in this condition, as discussed above.

Other conditions associated with chronic ulcers of the leg include autoimmune diseases (eg, Felty syndrome), arterial insufficiency (often very painful with absent pulses), sickle cell anemia, erythema induratum (bilateral and usually on the posterior aspect of the lower part of the leg), and fungal infections (cultures specific: no chronic swelling or varicosities).


when the patient is supine or bends over. There is progres-sive obstruction of the venous drainage of the head, neck, and upper extremities. The cutaneous veins of the upper chest and lower neck become dilated, and flushing of the face and neck develops. Brawny edema of the face, neck, and arms occurs later, and cyanosis of these areas then appears. Cerebral and laryngeal edema ultimately results in impaired function of the brain as well as respiratory insuf-ficiency. Bending over or lying down accentuates the symp-toms; sitting quietly is generally preferred. The manifestations are more severe if the obstruction develops rapidly and if the azygos junction or the vena cava between that vein and the heart is obstructed.


The venous pressure is elevated (often > 20 cm of water) in the arm and is normal in the leg. Since lung cancer is a common cause, bronchoscopy is often performed; trans-bronchial biopsy, however, is relatively contraindicated because of venous hypertension and the risk of bleeding.

C. imaging

Chest radiographs and a CT scan will define the location and often the nature of the obstructive process, and con-trast venography or magnetic resonance venography (MRV) will map out the extent and degree of the venous obstruction and the collateral circulation. Brachial venog-raphy or radionuclide scanning following intravenous injection of technetium Tc-99m pertechnetate demon-strates a block to the flow of contrast material into the right heart and enlarged collateral veins. These techniques also allow estimation of blood flow around the occlusion as well as serial evaluation of the response to therapy.

Treatment``

Urgent treatment for neoplasm consists of (1) cautious use of intravenous diuretics and (2) mediastinal irradiation, starting within 24 hours, with a treatment plan designed to give a high daily dose but a short total course of therapy to rapidly shrink the local tumor even further. Intensive com-bined therapy will palliate the process in up to 90% of patients. In patients with a subacute presentation, radia-tion therapy alone usually suffices. Chemotherapy is added if lymphoma or small-cell carcinoma is diagnosed.

Conservative measures, such as elevation of the head of the bed and lifestyle modification to avoid bending over, are useful. Balloon angioplasty of the obstructed caval seg-ment combined with stent placement provides prompt relief of symptoms and is the procedure of choice. Occasionally, anticoagulation is needed, while thromboly-sis is rarely needed. Long-term outcome is complicated by risk of re-occlusion from either thrombosis or further growth of neoplasm. Surgical procedures to bypass the obstruction are complicated by bleeding relating to high venous pressure. In cases where the thrombosis is second-ary to an indwelling catheter, thrombolysis may be attempted. Clinical judgment is required since a long-standing clot may be fibrotic and the risk of bleeding will outweigh the potential benefit.

prognosis``

Individuals with chronic venous insufficiency often have recurrent problems, particularly if they do not consistently wear support stockings that have at least 30 mm Hg compression.

When to refer``

• Patients with significant saphenous reflux should beevaluated for ablation as this may reduce the recirculation of blood and return the deep system to competence.

• Patientswithulcers shouldbemonitoredbyawoundcare team so that these challenging wounds can receive aggressive care.

Bergan JJ et al. Chronic venous disease. N Engl J Med. 2006 Aug 3; 355(5):488–98. [PMID: 16885552]

Eberhard RT et al. Chronic venous insufficiency. Circulation. 2005 May 10;111(18):2398–409. [PMID: 15883226]

Grey JE et al. Venous and arterial leg ulcers. BMJ. 2006 Feb 11; 332(7537):347–50. [PMID: 16470058]

Patel NP et al. Current management of venous ulceration. Plast Reconstr Surg. 2006 Jun;117(7 Suppl):254S–260S. [PMID: 16799394]

superiOr vena Caval OBsTruCTiOn

` `̀̀̀̀̀`̀̀̀`

swelling of the neck, face and upper extremities.` `̀̀̀̀̀`̀̀̀`

Dilated veins over the upper chest and neck.` `̀̀̀̀̀`̀̀̀`



Partial or complete obstruction of the superior vena cava is a relatively rare condition that is usually secondary to neo-plastic or inflammatory processes in the superior mediasti-num. The most frequent causes are (1) neoplasms, such as lymphomas, primary malignant mediastinal tumors, or carcinoma of the lung with direct extension (over 80%); (2) chronic fibrotic mediastinitis, either of unknown origin or secondary to tuberculosis, histoplasmosis, pyogenic infections, or drugs, especially methysergide; (3) DVT, often by extension of the process from the axillary or sub-clavian vein into the innominate vein and vena cava associ-ated with catheterization of these veins for dialysis or for hyperalimentation; (4) aneurysm of the aortic arch; and (5) constrictive pericarditis.



The onset of symptoms is acute or subacute. Symptoms include swelling of the neck and face, and upper extremi-ties. Symptoms are often perceived as congestion and pres-ent as headache, dizziness, visual disturbances, stupor, syncope, or cough. Symptoms are particularly exacerbated


Clinical Findings``


Throbbing pain is usually present in the area of cellulitis at the site of bacterial invasion. Malaise, anorexia, sweating, chills, and fever of 38–40 °C develop rapidly. The red streak, when present may be definite or may be very faint and easily missed, especially in dark-skinned patients. It is usually tender or indurated in the area of cellulitis. The involved regional lymph nodes may be significantly enlarged and are usually quite tender. The pulse is often rapid.


Leukocytosis with a left shift is usually present. Blood cul-tures may be positive, most often for staphylococcal or streptococcal species. Culture and sensitivity studies of the wound exudate or pus may be helpful in treatment of the more severe or refractory infections but are often difficult to interpret because of skin contaminants.


Lymphangitis may be confused with superficial throm-bophlebitis, but the erythema and induration of throm-bophlebitis is localized in and around the thrombosed vein. Venous thrombosis is not associated with lymphadenitis, and a wound of entrance with secondary cellulitis is gener-ally absent.

Cat-scratch fever should be considered when lymph-adenitis is present; the nodes, though often very large, are relatively nontender. Exposure to cats is common, but the patient may have forgotten about the scratch.

It is extremely important to differentiate cellulitis from acute streptococcal hemolytic gangrene or necrotizing fas-ciitis. These are deeper infections that may be extensive and are potentially lethal. Patients appear more seriously ill; there may be redness due to leakage of red cells, creating a non-blanching erythema; and subcutaneous crepitus may be palpated or auscultated using the diaphragm with light pressure over the involved area. Immediate wide debride-ment of all involved deep tissues should be done if these signs are present.

Treatment``

a. General Measures

Prompt treatment should include heat (hot, moist com-presses or heating pad), elevation when feasible, and immobilization of the infected area. Analgesics may be prescribed for pain.

B. specific Measures

Empiric antibiotic therapy for hemolytic streptococci or S aureus (or by both organisms) should always be instituted when local infection becomes invasive, as manifested by cellulitis and lymphangitis. Because such infections are so frequently caused by streptococci, cephalosporins or extended-spectrum penicillins are commonly used

prognosis``

The prognosis depends on the nature and degree of obstruction and its speed of onset. Slowly developing forms secondary to fibrosis may be tolerated for years. A high degree of obstruction of rapid onset secondary to cancer is often fatal in a few days or weeks because of increased intracranial pressure and cerebral hemorrhage, but treatment of the tumor with radiation and chemo-therapeutic drugs may result in significant palliation. Balloon angioplasty and stenting provides good relief but may require re-treatment for recurrent symptoms second-ary to thrombosis or restenosis.

When to refer``

Referral should occur with any patient with progressive head and neck swelling to rule out superior vena cava syndrome.

When to admit``

Any patient with acute edema of the head and neck or any patient in whom signs and symptoms of airway compro-mise, such as hoarseness or stridor, develop should be admitted.

Watkinson AF et al. Endovascular stenting to treat obstruction of the superior vena cava. BMJ. 2008 Jun 21;336(7658):1434–7. [PMID: 18566082]

Wilson LD et al. Clinical practice. Superior vena cava syndrome with malignant causes. N Engl J Med. 2007 May 3;356(18):1862–9. [PMID: 17476012]

DiseAses OF the lymphAtic chANNels

lyMpHanGiTis & lyMpHaDeniTis

` `̀̀̀̀̀`̀̀̀`

Red streak from wound or area of cellulitis toward ` `̀̀̀̀̀`̀̀̀`

regional lymph nodes, which are usually enlarged and tender.

Chills, fever, and malaise may be present.` `̀̀̀̀̀`̀̀̀`



Lymphangitis and lymphadenitis are common manifesta-tions of a bacterial infection that is usually caused by hemo-lytic streptococci or S aureus (or by both organisms) and usually arises from the site of an infected wound. The wound may be very small or superficial, or an established abscess may be present, feeding bacteria into the lymphatics. The involvement of the lymphatics is often manifested by a red streak in the skin extending in the direction of the regional lymph nodes, which are, in turn, generally tender and engorged. Systemic manifestations include fever, chills, and malaise. The infection may progress rapidly, often in a mat-ter of hours, and may lead to septicemia and even death.


Clinical Findings``

Hypertrophy of the limb results, with markedly thickened and fibrotic skin and subcutaneous tissue in very advanced cases.

Lymphangiography and radioactive isotope studies may identify focal defects in lymph flow but are of little value in planning therapy. T2–weighted MRI has been used to identify lymphatics and proximal obstructing masses.

Treatment``

Since there is no effective cure for lymphedema, the treat-ment strategies are designed to control the problem and allow normal activity and function. Most patients can be treated with some of the following measures: (1) The flow of lymph out of the extremity can be aided through inter-mittent elevation of the extremity, especially during the sleeping hours (foot of bed elevated 15–20 degrees, achieved by placing pillows beneath the mattress); the constant use of graduated elastic compression stockings; and massage toward the trunk—either by hand or by means of pneu-matic pressure devices designed to milk edema out of an extremity. (2) Secondary cellulitis in the extremity should be avoided by means of good hygiene and treatment of any trichophytosis of the toes. Once an infection starts, it should be treated by periods of elevation and antibiotic therapy that covers Staphylococcus and Streptococcus organisms (see Table 30–6). Infections can be a serious and recurring problem and are often difficult to control. Prophylactic antibiotics have not been shown to be of ben-efit. (3) Intermittent courses of diuretic therapy, especially in those with premenstrual or seasonal exacerbations, are rarely helpful. (4) Amputation is used only for the rare complication of lymphangiosarcoma in the extremity.

prognosis``

With aggressive treatment, including pneumatic compres-sion devices, good relief of symptoms can be achieved. The long-term outlook is dictated by the associated conditions and avoidance of recurrent cellulitis.

Ashikaga T et al; National Surgical Adjuvant Breast, Bowel Project. Morbidity results from the NSABP B-32 trial com-paring sentinel lymph node dissection versus axillary dissection. J Surg Oncol. 2010 Aug 1;102(2):111–8. [PMID: 20648579]

Haghighat S et al. Comparing two treatment methods for post mastectomy lymphedema: complex decongestive therapy alone and in combination with intermittent pneumatic compression. Lymphology. 2010 Mar;43(1):25–33. [PMID: 20552817]

Rockson SG. Diagnosis and management of lymphatic vascular disease. J Am Coll Cardiol. 2008 Sep 2;52(10):799–806. [PMID: 18755341]

Torres Lacomba M et al. Effectiveness of early physiotherapy to prevent lymphoedema after surgery for breast cancer: ran-domised, single blinded, clinical trial. BMJ. 2010 Jan 12;340:b5396. [PMID: 20068255]

(eg, cephalexin, 0.5 g orally four times daily for 7–10 days; see Table 30–6). Given the increasing incidence of methicillin-resistant S aureus (MRSA) in the community, coverage of this pathogen with appropriate antibiotic therapy (eg, trimethoprim-sulfamethoxazole, two double strength tablets twice daily for 7–10 days) should be con-sidered (see Tables 30–4 and 30–6).

C. Wound Care

Any wound that is the initiating site of lymphangitis should be treated aggressively. Any necrotic tissue must be debrided and loculated pus drained.

prognosis``

With proper therapy including an antibiotic effective against the invading bacteria, control of the infection can usually be achieved in a few days. Delayed or inad-equate therapy can lead to overwhelming infection with septicemia.

When to admit``

Infections causing lymphangitis should be treated in the hospital with intravenous antibiotics. Debridement may be required.

lyMpHeDeMa

` `̀̀̀̀̀`̀̀̀`

Painless persistent edema of one or both lower ` `̀̀̀̀̀`̀̀̀`

extremities, primarily in young women.

Pitting edema without ulceration, varicosities, or ` `̀̀̀̀̀`̀̀̀`

stasis pigmentation.

There may be episodes of lymphangitis and ` `̀̀̀`̀̀̀`̀`

cellulitis.



When lymphedema is due to congenital developmental abnormalities consisting of hypoplastic or hyperplastic involvement of the proximal or distal lymphatics, it is referred to as the primary form. The obstruction may be in the pelvic or lumbar lymph channels and nodes when the disease is extensive and progressive. The secondary form of lymphedema involves inflammatory or mechani-cal lymphatic obstruction from trauma, regional lymph node resection or irradiation, or extensive involvement of regional nodes by malignant disease or filariasis. Secondary dilation of the lymphatics that occurs in both forms leads to incompetence of the valve system, disrupts the orderly flow along the lymph vessels, and results in progressive stasis of a protein-rich fluid. Episodes of acute and chronic inflammation may be superimposed, with further stasis and secondary fibrosis.


1. septic shock—Sepsis is the most common cause of distributive shock and carries a mortality rate of 20–50%. Sepsis is typically secondary to bacteremia caused by such gram-negative organisms as Escherichia coli, Klebsiella, Proteus, and Pseudomonas and less often due to gram-negative anaerobes (eg, Bacteroides), but the incidence of sepsis from gram-positive bacteria (eg, S aureus) and fun-gal organisms is increasing. Risk factors include extremes of age, diabetes, immunosuppression, and history of a recent invasive procedure.

2. neurogenic shock—Neurogenic shock is caused by traumatic spinal cord injury or effects of an epidural or spinal anesthetic. This results in loss of sympathetic tone

shOcK

` `̀̀̀̀̀`̀̀̀`

Hypotension, tachycardia, oliguria, altered mental ` `̀̀̀̀̀`̀̀̀`

status.

Peripheral hypoperfusion and impaired oxygen ` `̀̀̀̀̀`̀̀̀`

delivery.



Shock occurs when the rate of arterial blood flow is inad-equate to meet tissue metabolic needs. This results in regional hypoxia and subsequent lactic acidosis from anaerobic metabolism in peripheral tissues as well as even-tual end-organ damage and failure.

Classification (Table 12–1)``

a. Hypovolemic shock

Hypovolemic shock results from decreased intravascular volume secondary to loss of blood or fluids and electro-lytes. The etiology may be suggested by the clinical setting (eg, trauma) or by signs and symptoms of blood loss (eg, gastrointestinal bleeding) or dehydration (eg, vomiting or diarrhea). Compensatory vasoconstriction may tran-siently maintain the blood pressure but unreplaced losses of over 15% of the intravascular volume can result in hypotension and progressive tissue hypoxia.

B. Cardiogenic shock

Cardiogenic shock results from cardiac failure with the resultant inability of the heart to maintain adequate tissue perfusion. The clinical definition of cardiogenic shock is evidence of tissue hypoxia due to decreased cardiac output (cardiac index < 2.2 L/min/m2) in the presence of adequate intravascular volume. This is most often caused by myocar-dial infarction but can also be due to cardiomyopathy, myocardial contusion, valvular incompetence or stenosis, or arrhythmias. See Chapter 10.

C. Obstructive shock

Cardiac tamponade, tension pneumothorax, and massive pulmonary embolism can cause an acute decrease in car-diac output resulting in shock. These are medical emergen-cies requiring prompt diagnosis and treatment.

D. Distributive shock

Distributive or vasodilatory shock has many causes includ-ing sepsis, anaphylaxis, systemic inflammatory response syndrome (SIRS) produced by severe pancreatitis or burns, traumatic spinal cord injury, or acute adrenal insufficiency. The reduction in systemic vascular resistance results in inadequate cardiac output and tissue hypoperfusion despite normal circulatory volume.

Table 12–1. Classification of shock by mechanism and common causes.

Hypovolemic shock Loss of blood (hemorrhagic shock) External hemorrhage Trauma Gastrointestinal tract bleeding Internal hemorrhage Hematoma Hemothorax or hemoperitoneum Loss of plasma Burns Exfoliative dermatitis Loss of fluid and electrolytes External losses Vomiting Diarrhea Excessive sweating Hyperosmolar states (diabetic ketoacidosis, hyperosmolar

nonketotic coma) Internal losses (third spacing) Pancreatitis Ascites Bowel obstruction Cardiogenic shock Dysrhythmia (tachyarrhythmia, bradyarrhythmia) “Pump failure” (secondary to myocardial infarction or other

cardiomyopathy) Acute valvular dysfunction (especially regurgitant lesions) Rupture of ventricular septum or free ventricular wall Obstructive shock Tension pneumothorax Pericardial disease (tamponade, constriction) Disease of pulmonary vasculature (massive pulmonary emboli,

pulmonary hypertension) Cardiac tumor (atrial myxoma) Left atrial mural thrombus Obstructive valvular disease (aortic or mitral stenosis) Distributive shock Septic shock Anaphylactic shock Neurogenic shock Vasodilator drugs Acute adrenal insufficiency

Reproduced, with permission, from Stone CK, Humphries RL (editors). Current Emergency Diagnosis & Treatment, 5th ed. p. 193. McGraw-Hill, 2004.


Septic shock is diagnosed when there is clinical evidence of infection in the setting of persistent hypotension and evidence of organ hypoperfusion, such as lactic acidosis, decreased urinary output, or altered mental status despite volume resuscitation. Neurogenic shock is diagnosed when there is evidence of central nervous system injury and per-sistent hypotension despite volume resuscitation.


Blood specimens should be evaluated for complete blood count, electrolytes, glucose, arterial blood gas determina-tions, coagulation parameters, lactate levels, typing and cross-matching, and bacterial cultures. An electrocardio-gram and chest radiograph should also be part of the initial assessment.

Treatment``

a. General Measures

Treatment depends on prompt diagnosis and an accurate appraisal of inciting conditions. Initial management con-sists of basic life support with an assessment of the patient’s airway, breathing, and circulation. This may entail airway intubation and mechanical ventilation. Ventilatory failure should be anticipated in patients with a severe metabolic acidosis in association with shock. Mechanical ventilation along with sedation can decrease the oxygen demand of the respiratory muscles and allow improved oxygen delivery to other hypoperfused tissues. Intravenous access and fluid resuscitation should be instituted along with cardiac mon-itoring and assessment of hemodynamic parameters such as blood pressure and heart rate. Cardiac monitoring can detect myocardial ischemia or malignant arrhythmias, which can be treated by standard advanced cardiac life sup-port (ACLS) protocols.

Unresponsive or minimally responsive patients should have their glucose checked immediately and if their glucose level is low, 1 ampule of 50% dextrose intravenously should be given. An arterial line should be placed for con-tinuous blood pressure measurement, and a Foley catheter should be inserted to monitor urinary output.

B. Central venous pressure

Early consideration is given to placement of a central venous catheter (CVC) for infusion of fluids and medica-tions and for hemodynamic pressure measurements. A CVC can provide measurements of the central venous pressure (CVP) and the central venous oxygen saturation, both of which can be used to manage sepsis. Pulmonary artery catheters (PACs) allow measurement of the pulmo-nary artery pressure, left-sided filling pressure or the pul-monary capillary wedge pressure (PCWP), and cardiac output. These catheters had previously been used in criti-cally ill patients to guide response to volume and vasopres-sor therapy, but data emerged suggesting that PACs increased mortality, prompting further studies. Meta-analyses of multiple studies, including randomized con-trolled trials, suggested that the use of PACs did not increase overall mortality or length of hospital stay, but was

with a reduction in systemic vascular resistance and hypotension without a compensatory tachycardia. Reflex vagal parasympathetic stimulation evoked by pain, gastric dilation, or fright may simulate neurogenic shock, produc-ing hypotension, bradycardia, and syncope.

Clinical Findings``


Hypotension is traditionally defined as a systolic blood pres-sure of ≤ 90 mm Hg or a mean arterial pressure of < 60–65 mm Hg but must be evaluated relative to the patient’s normal blood pressure. A drop in systolic pressure of > 10–20 mm Hg or an increase in pulse of > 15 beats per minute with posi-tional change suggests depleted intravascular volume. However, blood pressure is often not the best indicator of end-organ perfusion because compensatory mechanisms, such as increased heart rate, increased cardiac contractility, and vaso-constriction can occur to prevent hypotension. Patients with hypotension often have cool or mottled extremities and weak or thready peripheral pulses. Splanchnic vasoconstriction may lead to oliguria, bowel ischemia, and hepatic dysfunc-tion, which can ultimately result in multi-organ failure. Mentation may be normal or patients may become restless, agitated, confused, lethargic, or comatose as a result of inad-equate perfusion of the brain.

Hypovolemic shock is evident when signs of hypoper-fusion, such as oliguria, altered mental status, and cool extremities, are present. Jugular venous pressure is low, and there is a narrow pulse pressure indicative of reduced stroke volume. Rapid replacement of fluids restores tissue perfusion. In cardiogenic shock, there are also signs of global hypoperfusion with oliguria, altered mental status, and cool extremities. Jugular venous pressure is elevated and there may be evidence of pulmonary edema with respiratory compromise in the setting of left-sided heart failure. A transthoracic echocardiogram (TTE) or a TEE is an effective diagnostic tool to differentiate hypovolemic from cardiogenic shock. In hypovolemic shock, the left ventricle will be small because of decreased filling, but contractility is often preserved. Cardiogenic shock results from cardiac failure with a resultant decrease in left ven-tricular contractility. In some cases, the left ventricle may appear dilated and full because of the inability of the left ventricle to eject a sufficient stroke volume.

In obstructive shock, the central venous pressure may be elevated but the TEE or TTE may show reduced left ventricular filling, a pericardial effusion in the case of tam-ponade, or thickened pericardium as in the case of peri-carditis. Pericardiocentesis or pericardial window for pericardial tamponade, chest tube placement for tension pneumothorax, or catheter-directed thrombolytic therapy in the case of massive pulmonary embolism can be life-saving in cases of obstructive shock.

In distributive shock, signs include hyperdynamic heart sounds, warm extremities initially, and a wide pulse pressure indicative of large stroke volume. The echocardio-gram may show a hyperdynamic left ventricle. Fluid resus-citation may have little effect on blood pressure, urinary output, or mentation.


patients receiving hypertonic saline (7.5%) and those receiving isotonic crystalloid. More positive results were found with hypertonic saline plus dextran with an increase in survival over patients managed with isotonic saline, particularly in patients with traumatic brain injury.

D. early Goal-Directed Therapy

Early goal-directed therapy following set protocols for the treatment of septic shock provides significant benefits (see www.survivingsepsis.org). In a 2001 randomized controlled trial, patients with severe sepsis or septic shock were assigned to receive either 6 hours of early goal-directed therapy or usual care prior to admission to the intensive care unit. Patients assigned to early goal-directed care received fluid resuscitation to achieve a CVP of 8–12 mm Hg; vasopressors to maintain a mean arterial blood pres-sure of at least 65 mm Hg; PRBCs to reach a hematocrit of 30% if the central venous oxygen saturation was < 70%; and if, after PRBC transfusion, the central venous oxygen saturation remained < 70%, dobutamine to raise the cen-tral venous oxygen saturation > 70%. When compared with controls, these patients had a significantly lower in-hospital mortality rate (46.5% for standard therapy, 30.5% for early goal-directed therapy; P = .009) and 60-day mor-tality rate (57% for standard therapy, 44% for early goal-directed therapy; P = .03). A meta-analysis of hemodynamic optimization trials has also suggested that early treatment before the development of organ failure results in improved survival. Lactate clearance of > 10% can be used as a potential substitute for central venous oxygen saturation (ScvO2) criteria if ScvO2 monitoring is not available.

Compensated shock can occur in the setting of normal-ized hemodynamic parameters with ongoing global tissue hypoxia. Traditional endpoints of resuscitation such as blood pressure, heart rate, urinary output, mental status, and skin perfusion can therefore be misleading. Additional endpoints such as lactate levels and base deficit can help guide further resuscitative therapy. Patients who respond well to initial efforts demonstrate a survival advantage over nonresponders.

e. Medications

1. vasoactive therapy—Vasopressors and inotropic agents are administered only after adequate fluid resuscita-tion. Choice of vasoactive therapy depends on the pre-sumed etiology of shock as well as cardiac output. If there is evidence of low cardiac output with high filling pres-sures, inotropic support is needed to improve contractility. If there is continued hypotension with evidence of high cardiac output after adequate volume resuscitation, then vasopressor support is needed to improve vasomotor tone.

Dobutamine, a predominantly b-adrenergic agonist, is the first-line drug for cardiogenic shock, increasing contractility and decreasing afterload. The initial dose is 0.5–1 mcg/kg/min as a continuous intravenous infusion, which can be titrated every few minutes as needed to hemodynamic effect; the usual dosage range is 2–20 mcg/kg/min intravenously. Tachyphylaxis can occur after 48 hours secondary to the down-regulation of b-adrenergic receptors.

associated with higher use of inotropes and intravenous vasodilators in critically ill patients from different patient populations (including those with sepsis, myocardial isch-emia, and those who were postsurgical). Thus, the routine use of PACs cannot be recommended. However, in some complex situations, PACs may be useful in distinguishing between cardiogenic and septic shock. The attendant risks associated with PACs (such as infection, arrhythmias, vein thrombosis, and pulmonary artery rupture) can be as high as 4–9%; therefore, the value of the information they might provide must be carefully weighed in each patient. TTE is a noninvasive alternative to the PAC. TTE can provide infor-mation about the pulmonary artery pressure, PCWP, and cardiac output; in addition, TTE can provide valuable information about current cardiac function. There has been increasing evidence to suggest that respiratory varia-tion in radial artery pulse pressure or aortic blood flow may be more sensitive than CVP as a measure of fluid responsiveness in volume resuscitation in patients who are mechanically ventilated and in normal sinus rhythm, but this evidence is still evolving.

A CVP < 5 mm Hg suggests hypovolemia, and a CVP over 18 mm Hg suggests volume overload, cardiac failure, tamponade, or pulmonary hypertension. A cardiac index < 2 L/min/m2 indicates a need for inotropic support. A high cardiac index > 4 L/min/m2 in a hypotensive patient is consistent with early septic shock. The systemic vascular resistance is low (< 800 dynes · s/cm–5) in sepsis and neuro-genic shock and high (> 1500 dynes · s/cm–5) in hypov-olemic and cardiogenic shock. Treatment is directed at maintaining a CVP of 8–12 mm Hg, a mean arterial pres-sure of 65–90 mm Hg, a cardiac index of 2–4 L/min/m2, and a central venous oxygen saturation of > 70%.

C. volume replacement

Volume replacement is critical in the initial management of shock. Hemorrhagic shock is treated with immediate efforts to achieve hemostasis and rapid infusions of blood substitutes, such as type-specific or type O negative packed red blood cells (PRBCs) or whole blood, which also pro-vides extra volume and clotting factors. Each unit of PRBC or whole blood is expected to raise the hematocrit by 3%. Hypovolemic shock secondary to dehydration is managed with rapid boluses of isotonic crystalloid (0.9% saline or lactated Ringer solution) usually in 1-liter increments. Cardiogenic shock in the absence of fluid overload requires smaller fluid challenges, usually in increments of 250 mL. Septic shock usually requires large volumes of fluid for resuscitation (usually > 2 L) as the associated capillary leak releases fluid into the extravascular space. Caution must be used with large-volume resuscitation with unwarmed fluids because this can produce hypothermia, which can lead to hypothermia-induced coagulopathy. Warming of fluids before administration can avoid this complication.

Meta-analyses of studies of critically ill heterogenous populations comparing crystalloid and colloid resuscita-tion (with albumin) indicate no benefit of colloid over crystalloid solutions. Clinical trials and meta-analyses have also found no difference in mortality between trauma

www.survivingsepsis.org


not reduce mortality compared with norepinephrine in patients with septic shock who were being treated with catecholamine vasopressors. Some studies have reported reduced catecholamine requirements with vasopressin administration. Intravenous infusion of vasopressin at a low dose (0.01–0.04 units/min) may be safe and beneficial in septic patients with hypotension that is refractory to fluid resuscitation and conventional catecholamine vaso-pressors. Higher doses of vasopressin decrease cardiac output and may put patients at greater risk for splanchnic and coronary artery ischemia. The role of vasopressin in catecholamine-refractory shock or as an initial vasopressor is still unclear and warrants further study.

2. Corticosteroids—Corticosteroids are the treatment of choice in patients with shock secondary to adrenal insuf-ficiency. The observation that severe sepsis may be associ-ated with relative adrenal insufficiency or glucocorticoid receptor resistance has led to several trials to evaluate the role of treatment with corticosteroids in septic shock. Early trials where high doses of corticosteroids were adminis-tered to patients in septic shock did not show improved survival; rather, some worse outcomes were observed from increased rates of secondary infections. Subsequent trials have studied the use of low-dose corticosteroids in patients who were in septic shock and had relative adrenal insuffi-ciency, defined by a cortisol response of 9 mcg/dL or less after one injection of 250 mcg of corticotropin. Low-dose corticosteroid regimens included hydrocortisone 50 mg every 6 hours and 50 mcg of 9-alpha-fludrocortisone once a day, both for 7 days, or hydrocortisone 50 mg by intrave-nous bolus, followed by a continuous infusion of 0.18 mg/kg of body weight/h until cessation of vasopressor support. These trials demonstrated a shorter duration of use of vasopressors, significantly reduced 28-day mortality rates, and no increased adverse effects. There was no benefit from low-dose corticosteroid use in patients who did not have adrenal insufficiency. In 2008, the Corticosteroid Therapy of Septic Shock (CORTICUS) study demonstrated that low-dose hydrocortisone (50 mg intravenously every 6 hours for 5 days and then tapered over 6 days) did not improve survival in patients with septic shock, either over-all or in patients who did not respond to corticotropin. This study was a randomized, double-blinded, placebo-controlled trial that is the largest to date of corticosteroids in septic patients. One limitation of the CORTICUS trial was that it was not adequately powered to detect a clinically important difference in mortality. Thus, there is still uncer-tainty over the role of corticosteroids and corticotropin stimulation testing in patients with septic shock.

3. activated protein C (Drotrecogin alfa)—Activated protein C is an endogenous protein that has antithrom-botic, profibrinolytic, and anti-inflammatory properties. A large randomized trial published in 2001 demonstrated an improved 28-day mortality rate (from 31% to 25%) in patients with severe sepsis and organ failure when treated with recombinant human activated protein C (rhAPC). A retrospective follow up of the persons enrolled in the trial demonstrated that the survival benefit observed in patients with severe sepsis persisted only to hospital discharge. Post

Amrinone or milrinone are phosphodiesterase inhibitors that can be substituted for dobutamine. These drugs increase cyclic AMP levels and increase cardiac contractil-ity, bypassing the b-adrenergic receptor. However, vasodi-lation is a side effect of both amrinone and milrinone.

For vasodilatory shock when increased vasoconstric-tion is required to maintain an adequate perfusion pres-sure, a-adrenergic agonists such as norepinephrine and phenylephrine are generally used. Although norepineph-rine is both an a-adrenergic and b-adrenergic agonist, it preferentially increases mean arterial pressure over cardiac output. The initial dose is 1–2 mcg/min as an intravenous infusion, titrated to maintain the systolic blood pressure to at least 80 mm Hg. The usual maintenance dose is 2–4 mcg/min intravenously (maximum dose is 30 mcg/min). Patients with refractory shock may require dosages of 10–30 mcg/min intravenously. Epinephrine, also with both a-adrenergic and b-adrenergic effects, may be used in severe shock and during acute resuscitation. It is the vaso-pressor of choice for anaphylactic shock. For severe shock, give 1 mcg/min as a continuous intravenous infusion ini-tially and titrate to hemodynamic response; the usual dos-age range is 1–10 mcg/min intravenously.

Dopamine has variable effects according to dosage. At low doses (2–5 mcg/kg/min intravenously), stimulation of dopaminergic and b-adrenergic receptors produces increased glomerular filtration, heart rate, and contractil-ity. At doses of 5–10 mcg/kg/min, b1-adrenergic effects predominate, resulting in an increase in heart rate and cardiac contractility. At higher doses (> 10 mcg/kg/min), a-adrenergic effects predominate, resulting in peripheral vasoconstriction. The maximum dose is typically 50 mcg/kg/min.

There is no evidence documenting a survival benefit from, or the superiority of, a particular vasopressor in sep-tic shock. Norepinephrine and dopamine are the initial vasopressors of choice to maintain the mean arterial pres-sure > 65 mm Hg; however, a 2010 randomized controlled trial did demonstrate that arrhythmias were more com-mon in patients with shock who were treated with dop-amine than with norepinephrine. The clinician must consider using other agents such as phenylephrine if dys-rhythmias or tachycardias prevent the use of agents with b-adrenergic activity. While studies do not favor the use of vasopressin as first-line therapy, it may be useful as a second-line agent in the treatment of septic shock.

Vasopressin (antidiuretic hormone or ADH) is often used as an adjunctive therapy to catecholamine vasopres-sors in the treatment of distributive or vasodilatory shock. Vasopressin causes peripheral vasoconstriction via V1 receptors located on smooth muscle cells and attenua-tion of nitric oxide (NO) synthesis and cGMP, the second messenger of NO. The rationale for using low-dose vaso-pressin in the management of septic shock includes the relative deficiency of vasopressin in late shock and the increased sensitivity of the systemic circulation to the vaso-pressor effects of vasopressin. Vasopressin also potentiates the effects of catecholamines on the vasculature and stimulates cortisol production. In the Vasopressin and Septic Shock Trial (VASST), low doses of vasopressin did


hoc analysis, however, suggested that the benefit of rhAPC on long-term survival was greater in patients with APACHE (Acute Physiology and Chronic Health Evaluation) II scores ≥ 25. Subsequently, a randomized, placebo- controlled study from 2005 evaluating patients with severe sepsis and a low risk of death, as defined by an APACHE II score of < 25 or single organ failure, confirmed the finding of no mortality benefit at 28 days. Due to the number of conflict-ing studies, the PROWESS-SHOCK trial was designed to readdress the efficacy of activated protein C. This study took 1696 patients with septic shock and randomized them to receive drotrecogin alfa (activated) or placebo. The 28-day all-cause mortality was 26.4% in the patients receiving drotrecogin alfa (activated) and 24.2% in those receiving placebo, resulting in the withdrawal of the drug from the market by the manufacturer in 2011 since it failed to show a survival benefit in patients with severe sepsis and septic shock.

4. antibiotics—Definitive therapy for septic shock includes an early initiation of empiric broad-spectrum antibiotics after appropriate cultures have been obtained. Imaging studies may prove useful to attempt localization of sources of infection. Surgical management may also be necessary if necrotic tissue or loculated infections are present (see Table 30–5).

5. sodium bicarbonate—For patients with sepsis of any etiology and lactic acidosis, clinical studies have failed to show any hemodynamic benefit from bicarbonate therapy, either in increasing cardiac output or in decreasing the vaso-pressor requirement even in patients with severe acidemia.

F. Other Treatment Modalities

Cardiac failure may require use of transcutaneous or transvenous pacing or placement of an intra-arterial bal-loon pump. Emergent revascularization by percutaneous angioplasty or coronary artery bypass surgery appears to improve long-term outcome with increased survival com-pared with initial medical stabilization for patients with myocardial ischemia leading to cardiogenic shock. Urgent hemodialysis or continuous venovenous hemofiltration

may be indicated for maintenance of fluid and electrolyte balance during acute renal insufficiency resulting in shock from multiple modalities.

Castellanos-Ortega A et al. Impact of the Surviving Sepsis Campaign protocols on hospital length of stay and mortality in septic shock patients: results of a three-year follow-up quasi-experimental study. Crit Care Med. 2010 Apr;38(4): 1036–43. [PMID: 20154597]

COIITSS Study Investigators; Annane D et al. Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. JAMA. 2010 Jan 27; 303(4):341–8. [PMID: 20103758]

De Backer D et al; SOAP II Investigators. Comparison of dop-amine and norepinephrine in the treatment of shock. N Engl J Med. 2010 Mar 4;362(9):779–89. [PMID: 20200382]

Ferrer R et al; Edusepsis Study Group. Effectiveness of treat-ments for severe sepsis: a prospective, multicenter, observa-tional study. Am J Respir Crit Care Med. 2009 Nov 1;180(9): 861–6. [PMID: 19696442]

Levy MM et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med. 2010 Feb;38(2):367–74. [PMID: 20035219]

Marik PE et al. Recommendations for the diagnosis and man-agement of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med. 2008 Jun;36(6):1937–49. [PMID: 18496365]

Patel GP et al. Efficacy and safety of dopamine versus norepi-nephrine in the management of septic shock. Shock. 2010 Apr;33(4):375-80. [PMID: 19851126]

Prondzinsky R et al. Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome. Crit Care Med. 2010 Jan;38(1):152–60. [PMID: 19770739]

Rivers E et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001 Nov;345(19):1368–77. [PMID: 11794169]

Russell JA et al; VASST Investigators. Vasopressin versus norepi-nephrine infusion in patients with septic shock. N Engl J Med. 2008 Feb 28;358(9):877–87. [PMID: 18305265]

Sprung CL et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med. 2008 Jan;358(2):111–24. [PMID: 18184957]

Toussaint S et al. Activated protein C for sepsis. N Engl J Med. 2009 Dec 31;361(27):2646–52. [PMID: 20042756]

chuong 12

Documents

aorta iliac arteries

bilateral disease

bilateral common iliac

femoral arteries

disease progression

proximal common iliac

external iliac arteries

isolated aortoiliac